mymx_10q.htm

0001654954-22-015183.txt : 20221114 0001654954-22-015183.hdr.sgml : 20221114 20221114100500 ACCESSION NUMBER: 0001654954-22-015183 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 31 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYMETICS CORP CENTRAL INDEX KEY: 0000927761 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 251741849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-25132 FILM NUMBER: 221381587 BUSINESS ADDRESS: STREET 1: EUROPEAN EXECUTIVE OFFICE STREET 2: 4, ROUTE DE LA CORNICHE CITY: EPALINGES STATE: V8 ZIP: CH-1066 BUSINESS PHONE: 011-41-21-653-45-35 MAIL ADDRESS: STREET 1: EUROPEAN EXECUTIVE OFFICE STREET 2: 4, ROUTE DE LA CORNICHE CITY: EPALINGES STATE: V8 ZIP: CH-1066 FORMER COMPANY: FORMER CONFORMED NAME: ICHOR CORP DATE OF NAME CHANGE: 19970407 FORMER COMPANY: FORMER CONFORMED NAME: PDG REMEDIATION INC DATE OF NAME CHANGE: 19940801 10-Q 1 mymx_10q.htm FORM 10-Q mymx_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from __________ to _________

Commission file number: 000-25132

MYMETICS CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

25-1741849

State or Other jurisdiction of

Incorporation or Organization

I.R.S. Employer Identification No.

c/o Ernie Stern

1101 Pennsylvania Avenue, N.W., Suite 300

Washington D.C.

United States

USA-20004

Address

Zip Code

c/o Mymetics SA

Route de la Corniche 4

Epalinges, Switzerland

CH-1066

Address of Principal Executive Offices

Zip Code

011 41 21 653 4535

Registrant’s Telephone Number, Including Area Code

_______________________________________________________________________

Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, Par Value $0.01 per share		MYMX		OTCQB venture stage marketplace

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large-accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large-accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large-accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

APPLICABLE ONLY TO CORPORATE ISSUERS

The number of shares outstanding of the Registrant’s Common Stock, $0.01 par value, was 303,757,622 as of November 14, 2022

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MYMETICS CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands of Euros, Except Share and Par Value)

	September 30,			December 31,
	2022			2021
	(unaudited)
ASSETS
Current Assets
Cash	€	401		€	571
Accounts receivable		58			15
Prepaid expenses		138			87
Total current assets		597			673

Rent deposit		10			10
Property and equipment, net of accumulated depreciation of €483 at September 30, 2022 and €474 at December 31, 2021		30			39
Right-of-Use Asset		159			239
Goodwill		6,671			6,671
Total	€	7,467		€	7,632

LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable	€	48		€	47
Operating Lease Liability		106			110
Non-convertible notes payable and related accrued interest to related parties		10,151			8,790
Convertible notes payable and related accrued interest to related parties		60,915			58,479
Total current liabilities		71,220			67,426

Long Term Liabilities
Debt-Principal Payable to the Federal Financing Bank		176			162
Operating lease liability		57			130
Total long-term liabilities		233			292
		71,453			67,718

Commitments and Contingencies (Note 3)		-			-

Shareholders' Deficit
Common stock, U.S. $0.01 par value; 1,200,000,000 shares authorized; issued and outstanding 303,757,622 at September 30, 2022 and at December 31, 2021		2,530			2,530
Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none-issued or Outstanding		-			-
Additional paid-in capital		34,443			34,443
Accumulated deficit		(101,648	)		(97,750	)
Accumulated other comprehensive income		689			691
Total shareholders’ deficit		(63,986	)		(60,086	)
Total liabilities and shareholders’ deficit	€	7,467		€	7,632

The accompanying notes are an integral part of these condensed consolidated financial statements.

MYMETICS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(UNAUDITED)

(In Thousands of Euros, Except Per Share Data)

	For The Three Months Ended September 30,						For The Nine Months Ended September 30,
	2022			2021			2022			2021

Revenue
Other	€	-		€	-		€	3		€	-
Research and development		-			-			-			3
Grants		130			82			909			372
Revenue total		130			82			912			375
Expenses
Research and development		209			190			1,191			752
General and administrative		320			260			979			828
Expenses total		529			450			2,170			1,580

Operating Loss		(399	)		(368	)		(1,258	)		(1,205	)

Interest expense		703			688			2,096			2,057
Other (income) expense		243			86			544			186
Loss before income tax provision		(1,345	)		(1,142	)		(3,898	)		(3,448	)

Income tax provision		-			(11	)		-			(53	)
Net Loss		(1,345	)		(1,153	)		(3,898	)		(3,501	)

Other comprehensive income
Foreign currency translation adjustment		(7	)		(5	)		(2	)		(12	)
Comprehensive loss	€	(1,352	)	€	(1,158	)	€	(3,900	)	€	(3,513	)

Basic and dilutive earnings per share	€	(0.00	)	€	(0.00	)	€	(0.01	)	€	(0.01	)
Weighted-average shares outstanding, basic and diluted		303,757,622			303,757,622			303,757,622			303,757,622

The accompanying notes are an integral part of these condensed consolidated financial statements.

MYMETICS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT

(UNAUDITED)

(In Thousands of Euros)

	Three and Nine-month Period Ended September 30, 2021
	Common Stock Number of Par						Accumulated			Accumulated Other Comprehensive
	Shares		Value		APIC		deficit			Income			Total

Balance at December 31, 2020		303,757,622	E	2,530	E	34,443	E	(93,020	)	E	695		E	(55,352	)

Net loss		-		-		-		(1,246	)		-			(1,246	)
Translation adjustment		-		-		-		-			(8	)		(8	)
Balance at March 31, 2021		303,757,622	E	2,530	E	34,443	E	(94,266	)	E	687		E	(56,606	)

Net loss		-		-		-		(1,102	)		-			(1,102	)
Translation adjustment		-		-		-		-			1			1
Balance at June 30, 2021		303,757,622	E	2,530	E	34,443	E	(95,368	)	E	688		E	(57,707	)

Net loss		-		-		-		(1,153	)		-			(1,153	)
Translation adjustment		-		-		-		-			(5	)		(5	)
Balance at September 30, 2021		303,757,622	E	2,530	E	34,443	E	(96,521	)	E	683		E	(58,865	)

	Three and Nine-month Period Ended September 30, 2022
	Common Stock Number of Par						Accumulated			Accumulated Other Comprehensive
	Shares		Value		APIC		deficit			Income			Total

Balance at December 31, 2021		303,757,622	E	2,530	E	34,443	E	(97,750	)	E	691		E	(60,086	)

Net loss		-		-		-		(1,211	)		-			(1,211	)
Translation adjustment		-		-		-		-			7			7
Balance at March 31, 2022		303,757,622	E	2,530	E	34,443	E	(98,961	)	E	698		E	(61,290	)

Net loss		-		-		-		(1,342	)		-			(1,342	)
Translation adjustment		-		-		-		-			(2	)		(2	)
Balance at June 30, 2022		303,757,622	E	2,530	E	34,443	E	(100,303	)	E	696		E	(62,634	)

Net loss		-		-		-		(1,345	)		-			(1,345	)
Translation adjustment		-		-		-		-			(7	)		(7	)
Balance at September 30, 2022		303,757,622	E	2,530	E	34,443	E	(101,648	)	E	689		E	(63,986	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

MYMETICS CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(In Thousands of Euros)

	For The Nine Months Ended			For The Nine Months Ended
	September 30, 2022			September 30, 2021
Cash Flow from Operating Activities
Net loss	€	(3,898	)	€	(3,501	)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation		11			14
Changes in operating assets and liabilities
Receivables		(43	)		39
Accrued interest on convertible notes payable		2,436			2,083
Accrued interest on non-convertible notes payable		161			136
Accounts payable		1			-
Deferred grant		-			13
Other		(34	)		(43	)
Net cash used in operating activities		(1,366	)		(1,259	)

Cash Flows from Investing Activities
Purchase of property and equipment		(2	)		(10	)
Net cash used in investing activities		(2	)		(10	)

Cash Flows from Financing Activities
Proceeds from borrowing on-line of credit with federal bank		-			-
Proceeds from issuance of non-convertible notes		1,200			1,200
Net cash provided by financing activities		1,200			1,200

Effect on foreign exchange rate on cash		(2	)		(12	)
Net change in cash		(170	)		(81	)

Cash, beginning of period		571			1,083
Cash, end of period	€	401		€	1,002

Supplemental Disclosure of Cash Flow Information:
Cash paid for taxes		-			(48	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

MYMETICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

Note 1. The Company and Summary of Significant Accounting Policies

BASIS OF PRESENTATION AND GOING CONCERN

The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts.

The accompanying interim period condensed consolidated financial statements of Mymetics Corporation (the "Company") set forth herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such SEC rules and regulations. The interim period condensed consolidated financial statements should be read together with the audited financial statements and the accompanying notes included in the Company's latest annual report on Form 10-K for the fiscal year ended December 31, 2021.

The accompanying financial statements of the Company are unaudited. However, in the opinion of the Company, the unaudited condensed consolidated financial statements contained herein contain all adjustments necessary to present a fair statement of the results of the interim periods presented. All adjustments made during the three and nine-month period ending September 30, 2022 were of a normal and recurring nature.

The Company was created for the purpose of engaging in vaccine research and development. Its main research efforts in the beginning have been concentrated in the prevention and treatment of the AIDS virus and malaria. The Company has established a network which enables it to work with education centers, research centers, pharmaceutical laboratories and biotechnology companies. Besides the HIV and malaria vaccine candidates, the Company additionally has generated preclinical data for the following vaccines: Herpes Simplex and Respiratory Syncytial Virus (“RSV”), neither of which is currently being developed. The company also has clinical data for an intranasal influenza vaccine for the elderly which has finished a Phase I clinical trial and is currently on hold. As of September 30, 2022, the Company is working on several research projects for immunotherapy in the field oncology and for some infectious diseases with academic partners. Since April 2020, the Company has additionally started to work on the development of an intranasal virosome-based vaccine to prevent Covid-19, the disease caused by the SARS-CoV-2 virus. For the Covid-19 vaccine candidates, the Company is collaborating with leading academic institutions, such as Baylor College of Medicine in Texas, the Amsterdam Medical Center (AMC) of the University of Amsterdam in the Netherlands and the University Hospital in Bern, Switzerland.

As of September 30, 2022, the Company was engaged in the pre-clinical testing of some of its vaccine candidates, but a commercially viable product is not expected for several more years. However, the Company generated some revenue through collaboration and grant agreements.

These consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced negative cash flows from operations and significant losses since inception resulting in an accumulated deficit of €101,648 at September 30, 2022. Further, the Company’s current liabilities exceed its current assets by €70,623 as of September 30, 2022, and there is no assurance that cash will become available to pay current liabilities in the near term. Management is seeking additional financing but there can be no assurance that management will be successful in any of those efforts. These conditions raise substantial doubt about our ability to continue as a going concern within one year from the issuance of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

LEASES

Effective January 1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use ("ROU") asset and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease, the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding right-of- use ("ROU") asset. Lease liabilities represent the present value of our future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company’s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.

IMPACT OF THE NOVEL CORONAVIRUS

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally.

The COVID-19 pandemic has continued to evolve. Although at this date the restrictive measures and impacts are reduced due to the role out of vaccination programs, the extent to which the outbreak impacts our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, emergence of new variants, the duration of the pandemic, travel restrictions and social distancing, business closures or business disruptions and the effectiveness of actions taken in the U.S., Europe, and other countries to contain and treat the disease. As such, it is uncertain as to the full magnitude that the pandemic will have on the Company’s financial condition, liquidity, and future results of operations.

Management has taken measures in-line with the country requirements where we are operating, and we are actively monitoring the global situation on its financial condition, liquidity, operations, scientific collaborations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022.

The Company is dependent on its workforce to deliver and advance its research. Developments such as physical distancing and working from home directives have and will continue to impact the Company’s ability to deploy its workforce effectively. While restrictions are being lifted across the world, prolonged workforce disruptions may negatively impact future revenues for the remainder of fiscal year 2022 and the Company’s overall liquidity.

The Company is dependent on its partners in certain projects, such as the University of Louisiana at Lafayette (“ULL”) for the NIH funded project to maintain the agreed timelines and execute their tasks. Developments such as social distancing and shelter-in-place directives and lock-down directives have and will continue to impact the Company’s ability to execute on project plans and research objectives effectively. While expected to be temporary, prolonged disruptions in collaboration projects may negatively impact funding for the fiscal year 2022 and the Company’s overall liquidity.

Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it may have a material adverse effect on the Company’s results of future operations, financial position, and liquidity for the fiscal year 2022.

CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT

On March 27, 2020, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. The CARES Act includes various income and payroll tax provisions. The Company has analyzed the tax provisions of the CARES Act and determined they have no significant financial impact to the condensed financial statements. The Company has no intention of taking advantage of other benefits provided by the CARES Act but will continue to evaluate the impact on the Company’s financial position.

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.

NEW ACCOUNTING PRONOUNCEMENT

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. Specifically, ASU 2020-06 simplifies accounting for the issuance of convertible instruments by removing major separation models required under current GAAP. In addition, the ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share (EPS) calculation in certain areas. ASU 2020-06 will be effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, beginning in fiscal years which begin after December 15, 2020. The FASB has specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluating the impact of the pending adoption of this new standard on its consolidated financial statements.

FOREIGN CURRENCY TRANSLATION

The Company translates non-Euro assets and liabilities of its subsidiaries at the rate of exchange at the balance sheet date. Revenues and expenses are translated at the average rate of exchange throughout the period. Unrealized gains or losses from these translations are reported as a separate component of comprehensive income. Transaction gains or losses are included in foreign exchange (gain) loss in the consolidated statements of comprehensive loss. The translation adjustments do not recognize the effect of income tax because the Company expects to reinvest the amounts indefinitely in operations. The Company's reporting currency is the Euro because substantially all of the Company's activities are conducted in Europe.

CASH

The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts.

REVENUE RECOGNITION

Effective January 1, 2018, the Company adopted Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers, using the modified retrospective method and there was no impact to financial position and results of operations as a result of the adoption. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under Topic 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Overall, adoption of the new standard did not result in an adjustment to amounts previously reported in our consolidated financial statements and there were no other significant changes impacting the timing or measurement of our revenue or our business processes and controls.

The Company has concluded that government grants are not within the scope of Topic 606, as they do not meet the definition of a contract with a “customer”. The Company concluded the definition of a contract with a “customer” was not met as the counterparty to the government grants has not contracted to obtain goods or services and thus the contracts are not considered to have commercial substance. Government grants provide the Company with payments for certain types of expenditures related to research and development activities over a contractually defined period. Revenue from government grants is recognized in the period during which the related costs are incurred, provided that the applicable conditions under the government contracts have been met.

NIH

On April 29, 2019, the National Institutes of Health (“NIH”) awarded the Company and Texas Biomedical Research Institute (“Texas Biomed”) a five-year grant for the project called “Cold Chain-independent, Needle-free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels” (“NIH Grant”). The project started on May 1, 2019 and is planned for five years. It was initially co-led by Texas Biomed, but due to the move of Dr. Ruth Ruprecht, the Co-Principal Investigator, to the University of Louisiana at Lafayette (“ULL”) at the end of 2019, ULL has become the co-lead with Mymetics for this project. The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fourth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616.

The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in May 2022 for the fourth year.

The cost incurred and granted under the sub-award with Texas Biomed for the period of May to December 2019 was US$547 (€542). The sub-award contract between ULL and the Company for the period of January 2020 to April 2021, was signed for a total budget of US$870 and US$1,078 for the period May 2021 to April 2022. The total grant revenue incurred as of today is US$2,796 (€2,511), of which US$971 (€909) has been incurred during the nine-months ended September 30, 2022. First results are expected to be reported in 2023.

The project has the objective to prepare the Company’s promising HIV-1 vaccine candidate for clinical trials, by first executing a non-human primate (“NHP”) study, where the test subjects will be receiving Mymetics’ virosome based HIV-1 vaccine candidate by several intra-muscular and intra-nasal applications, followed by rectal challenges. As of September 30, 2022, Mymetics has successfully produced five sets of virosome based vaccines and the NHPs have received two intramuscular vaccinations and three intranasal vaccinations in two different studies. The vaccinations were well tolerated. These studies are ongoing. The vaccine is created to induce protective mucosal antibodies acting as a frontline defense against sexual HIV transmission. This awarded grant from the NIH will allow the Company to continue some of the developments that were achieved during the European Horizon 2020 project.

In February 2022, Mymetics announced the publication of results in Frontiers in Immunology title: “Cooperation between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques against Mucosal SHIV challenges”.

Option to License Agreement – ANERGIS SA

In April 2018 Mymetics engaged in a Research and Option to License Agreement with Anergis SA. Under the agreement, a mice proof-of-concept immunogenicity study evaluated the effects of the Bet v 1 COPs (Anergis’ proprietary birch pollen allergy peptides) using the five subcutaneous injection schedules used in former AllerT clinical trials. The development of AllerT (Bet v 1 COPs plus aluminum hydroxide) was discontinued by Anergis in 2017 following completion of a Phase 2 clinical trial showing evidence of sensitization to the peptides and a 7% reduction in seasonal allergy symptoms vs placebo (p=0.0047). In the mice study, AllerT was compared to Bet v 1 COPs linked to Mymetics’ virosomes (the “Bet v 1 COP-virosomes”).

In December 2018 Anergis and Mymetics reported that the administration of AllerT led to the development of Bet v 1 specific IgEs (p<0.001) associated with a more pronounced TH2 than TH1 response. In contrast, in the mice receiving the Bet v 1 COP-virosomes, no development of Bet v 1 specific IgEs were observed (p<0.001 vs AllerT). With the same dose of Bet v 1 COPs, there was a strong boost of immunogenicity with a TH1 antibody response, which was a hundred times greater than with aluminum hydroxide (p<0.001). The Bet v 1 COP-virosomes were well tolerated. The success criteria were met and Anergis had a time limited option to enter into an exclusive license agreement with Mymetics for the use of virosomes in the field of allergies.

In October 2019, Mymetics announced that Anergis SA started a new study with Stallergenes Greer SA whereby the COP-Virosomes were tested in the therapeutic mouse model of birch allergy in comparison with positive controls, i.e., birch allergen and birch pollen extract. This model has been confirmed as having predictive value towards the future clinical efficacy of new AIT treatment candidates.

In May 2020, Mymetics announced the results of the study with Stallergenes Greer, a worldwide leader in allergen immunotherapy (AIT) and Anergis, a leader in ultra-fast AIT research and development. The results showed that a treatment with COP-virosomes was able to cure allergic asthma in birch pollen sensitized mice and that the COP-virosomes were significantly superior to the COP or the virosome alone, confirming the synergy between COP and virosomes to foster an improved second-generation AIT treatment.

In January 2021, following the two successful studies with its virosome platform, Mymetics announced the acceptance of its joint publication in the scientific journal Clinical & Experimental Allergy with Stallergenes Greer SA and Anergis SA, with the title: Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.

As of February 1, 2021, Anergis SA has entered into liquidation since it was not able to raise sufficient funds to continue to operate. As of June 17, 2022, Anergis SA has entered into bankruptcy proceedings.

RECEIVABLES

Receivables are stated at their outstanding principal balances. Management reviews the collectability of receivables on a periodic basis and determines the appropriate amount of any allowance. There was no allowance necessary at September 30, 2022 or December 31, 2021. The Company writes off receivables to the allowance when management determines that a receivable is not collectible. The Company may retain a security interest in the products sold.

PROPERTY AND EQUIPMENT

Property and equipment is recorded at cost and is depreciated over its estimated useful life on straight-line basis from the date placed in service. Estimated useful lives are usually taken as three years.

IMPAIRMENT OF LONG-LIVED ASSETS

Long-lived assets, which include property and equipment, are assessed for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The impairment testing involves comparing the carrying amount to the forecasted undiscounted future cash flows generated by that asset. In the event the carrying value of the assets exceeds the undiscounted future cash flows generated by that asset and the carrying value is not considered recoverable, impairment exists. An impairment loss is measured as the excess of the asset’s carrying value over its fair value, calculated using a discounted future cash flow method. An impairment loss would be recognized in net income (loss) in the period that the impairment occurs.

GOODWILL

Goodwill represents the excess of purchase price over the value assigned to the net tangible and identifiable intangible assets of a business acquired. The Company typically performs its annual goodwill impairment test effective as of April 1 of each year, unless events or circumstances indicate impairment may have occurred before that time. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than it’s carrying amount. After assessing qualitative factors, the Company determined that no further testing was necessary. If further testing was necessary, the Company would determine the fair value of each reporting unit and compare the fair value to the reporting unit’s carrying amount. The Company has one reporting unit.

RESEARCH AND DEVELOPMENT

Research and development costs are expensed as incurred.

WITHHOLDING TAXES

On March 10, 2021, the Swiss Federal tax administration conducted a withholding tax audit on Mymetics SA’s financial statements for the years 2015 to 2019. At the end of the tax audit, the tax inspector concluded that a portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA could be considered as a hidden dividend distribution and therefore subject to Swiss withholding tax. The tax inspector encouraged the Company to file the relevant Swiss withholding tax forms to benefit from the double tax treaty between Switzerland and the United States. All required documentation has been sent, assessed and approved by the Swiss Federal tax administration. The portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA is considered as a hidden dividend distribution and therefore subject to Swiss withholding tax at a reduced tax rate of 5% and based on the double tax treaty in force between Switzerland and the United State of America. All required tax declaration forms have been filed and the related withholding tax amounts have been accounted for as of December 31, 2021.

TAXES ON INCOME

The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than enactments of changes in the tax laws or rates.

The Company reports a liability, if any, for unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return. Estimated interest and penalties, if any, are recorded as a component of interest expense and other expense, respectively.

The Company has not recorded any liabilities for uncertain tax positions or any related interest and penalties at September 30, 2022 nor December 31, 2021. The Company’s United States tax returns are open to audit for the years ended December 31, 2015 to 2019. The returns for the Swiss subsidiary, Mymetics S.A., are open to audit for the year ended December 31, 2021. The returns for the Netherlands subsidiaries, Bestewil B.V. and Mymetics B.V., are open to audit for the year ended December 31, 2021.

EARNINGS PER SHARE

Basic earnings per share is computed by dividing net income or loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. Diluted earnings per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. For the periods ended September 30, 2022 and 2021, options and convertible debt were not included in the computation of diluted earnings per share because their effect would be anti-dilutive due to net losses incurred under the treasury stock method.

For the three and nine months ended September 30, 2022, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 793,630,391 at September 30, 2022 includes 767,880,391 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees.

For the three and nine months ended September 30, 2021, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 757,030,713 at September 30, 2021 includes 731,280,713 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees.

PREFERRED STOCK

The Company has authorized 5,000,000 shares of preferred stock that may be issued in several series with varying dividend, conversion and voting rights. No preferred shares are issued or outstanding at September 30, 2022 or December 31, 2021.

ESTIMATES

The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

FAIR VALUE MEASUREMENTS

Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:

	Level 1-		Quoted prices in active markets for identical assets or liabilities.
	Level 2-		Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3-		Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

FAIR VALUES OF FINANCIAL INSTRUMENTS

The Company generally has the following financial instruments: cash, receivables, accounts payable, and notes payable. The carrying value of cash, accounts receivable, and accounts payable, approximates their fair value based on the short-term nature of these financial instruments. Management believes the fair value of the note’s payable is reflecting the actual value reported for these instruments.

CONCENTRATIONS

The Company derived 100% and 99% of grant revenue for the nine-month periods ended September 30, 2022 and 2021, from one grantor, respectively. For the period ended December 31, 2021, the Company derived 95% of grant revenue from one partner.

RELATED PARTY TRANSACTIONS

Mr. Ernest M. Stern, the Company’s outside U.S. counsel, is both a director of the Company and is a partner in Culhane Meadows PLLC, the firm retained as legal counsel by the Company. The Company incurred professional fees to the counsel's law firms totaling €10 and €6 for the three months ended September 30, 2022 and 2021 respectively; and €40 and €17 for the nine months ended September 30, 2022 and 2021, respectively.

Two of the Company’s major shareholders have granted secured convertible notes and short-term convertible notes and promissory notes, which have a total carrying amount of €70,603 including interest due as of September 30, 2022. Conversion prices on the Euro-denominated convertible debt have been fixed to a fixed Euro/US dollar exchange rate.

Note 2. Debt Financing

Certain principal shareholders have granted the Company secured convertible notes (in accordance with the Uniform Commercial Code in the State of Delaware), short term convertible notes and other short-term notes, which have a total carrying value of €71,066 including interest due to date. Interest incurred on these notes since inception has been added to the principal amounts.

The details of the convertible notes and loans are as follows at September 30, 2022:

										Fixed
								Conversion		Rate
Lender	1st-Issue	Principal		Duration			Interest	Price		EUR/USD
Price	Date	Amount		(Note)			Rate	(stated)		Conversion

Eardley Holding A.G. (1)	06/23/2006	€	194		(2	)	10% pa	$	0.10		N/A
Anglo Irish Bank S.A.(3)	10/21/2007	€	500		(2	)	10% pa	$	0.50		1.4090
Round Enterprises Ltd.	12/10/2007	€	1,500		(2	)	10% pa	$	0.50		1.4429
Round Enterprises Ltd.	01/22/2008	€	1,500		(2	)	10% pa	$	0.50		1.4629
Round Enterprises Ltd.	04/25/2008	€	2,000		(2	)	10% pa	$	0.50		1.5889
Round Enterprises Ltd.	06/30/2008	€	1,500		(2	)	10% pa	$	0.50		1.5380
Round Enterprises Ltd.	11/18/2008	€	1,200		(2	)	10% pa	$	0.50		1.2650
Round Enterprises Ltd.	02/09/2009	€	1,500		(2	)	10% pa	$	0.50		1.2940
Round Enterprises Ltd.	06/15/2009	€	5,500		(2,4	)	10% pa	$	0.80		1.4045
Eardley Holding A.G.	06/15/2009	€	100		(2,4	)	10% pa	$	0.80		1.4300
Von Meyenburg	08/03/2009	€	200		(2	)	10% pa	$	0.80		1.4400
Round Enterprises Ltd.	10/13/2009	€	2,000		(2	)	5% pa	$	0.25		1.4854
Round Enterprises Ltd.	12/18/2009	€	2,200		(2	)	5% pa	$	0.25		1.4338
Round Enterprises Ltd.	08/04/2011	€	1,225		(5,6	)	10% pa	$	0.034		N/A
Eardley Holding A.G.	08/04/2011	€	306		(5,6	)	10% pa	$	0.034		N/A
Round Enterprises Ltd.	11/08/2011	€	400		(6	)	10% pa	$	0.034		1.3787
Eardley Holding A.G.	11/08/2011	€	100		(6	)	10% pa	$	0.034		1.3787
Round Enterprises Ltd.	02/10/2012	€	1,000		(6	)	10% pa	$	0.034		1.3260
Eardley Holding A.G.	02/14/2012	€	200		(6	)	10% pa	$	0.034		1.3260
Round Enterprises Ltd.	04/19/2012	€	322		(6	)	10% pa	$	0.034		1.3100
Eardley Holding A.G.	04/19/2012	€	80		(6	)	10% pa	$	0.034		1.3100
Round Enterprises Ltd.	05/04/2012	€	480		(6	)	10% pa	$	0.034		1.3152
Eardley Holding A.G.	05/04/2012	€	120		(6	)	10% pa	$	0.034		1.3152
Round Enterprises Ltd.	09/03/2012	€	200		(6	)	10% pa	$	0.034		1.2576
Eardley Holding A.G.	09/03/2012	€	50		(6	)	10% pa	$	0.034		1.2576
Round Enterprises Ltd.	11/14/2012	€	500		(6	)	10% pa	$	0.034		1.2718
Eardley Holding A.G.	12/06/2012	€	125		(6	)	10% pa	$	0.034		1.3070
Round Enterprises Ltd.	01/16/2013	€	240		(6	)	10% pa	$	0.034		1.3318
Eardley Holding A.G.	01/16/2013	€	60		(6	)	10% pa	$	0.034		1.3318
Round Enterprises Ltd.	03/25/2013	€	400		(6	)	10% pa	$	0.037		1.2915
Eardley Holding A.G.	04/14/2013	€	150		(6	)	10% pa	$	0.034		1.3056
Round Enterprises Ltd.	04/14/2013	€	600		(6	)	10% pa	$	0.034		1.3056
Eardley Holding A.G.	05/15/2013	€	170		(6	)	10% pa	$	0.037		1.2938
Round Enterprises Ltd.	05/15/2013	€	680		(6	)	10% pa	$	0.037		1.2938
Eardley Holding A.G.	06/24/2013	€	60		(6	)	10% pa	$	0.025		1.3340
Round Enterprises Ltd.	06/24/2013	€	240		(6	)	10% pa	$	0.025		1.3340
Eardley Holding A.G.	08/05/2013	€	80		(6	)	10% pa	$	0.018		1.3283
Round Enterprises Ltd.	08/05/2013	€	320		(6	)	10% pa	$	0.018		1.3283
Eardley Holding A.G.	03/01/2017	€	230		(7	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	03/01/2017	€	920		(7	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	10/18/2017	€	230		(7	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	10/18/2017	€	920		(7	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	06/01/2018	€	160		(8	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	06/01/2018	€	640		(8	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	11/10/2018	€	160		(8	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	11/10/2018	€	640		(8	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	06/15/2019	€	120		(9	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	06/15/2019	€	480		(9	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	12/20/2019	€	120		(10	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	12/20/2019	€	480		(10	)	2.5% pa		N/A		N/A
Eardley Holding AG	06/15/2020	€	220		(11	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	06/15/2020	€	880		(11	)	2.5% pa		N/A		N/A
Eardley Holding AG	12/15/2020	€	170		(12	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	12/15/2020	€	680		(12	)	2.5% pa		N/A		N/A
Eardley Holding AG	08/15/2021	€	240		(13	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	08/15/2021	€	960		(13	)	2.5% pa		N/A		N/A
Eardley Holding AG	04/30/2022	€	120		(14	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	04/30/2022	€	480		(14	)	2.5% pa		N/A		N/A
Eardley Holding AG	08/15/2022	€	120		(14	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	08/15/2022	€	480		(14	)	2.5% pa		N/A		N/A
Total Short Term Principal Amounts		€	37,452
Accrued Interest		€	33,614
TOTAL LOANS AND NOTES		€	71,066

(1) Private investment company of Dr. Thomas Staehelin, member of the Board of Directors and of the Audit Committee of the Company. Face value is stated in U.S. dollars at $190.

(2) This maturity date is automatically prolonged for periods of three months, unless called for repayment.

(3) Renamed Hyposwiss Private Bank Genève S.A. and acting on behalf of Round Enterprises Ltd. which is a major shareholder.

(4) The loan is secured against 2/3rds of the IP assets of Bestewil Holding BV and against all property of the Company.

(5) The face values of the loans are stated in U.S. dollars at $1,200 and $300, respectively.

(6) This maturity date is automatically prolonged for periods of three months, unless called for repayment. The conversion price per share is determined by the lower of (i) reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above. The convertible note holder has the right to convert at any time prior to the maturity date, at the convertible note holder’s option, prior to the repayment of the outstanding balance under the note by the Company, to convert the unpaid outstanding principal balance and accrued interest, in whole or in part, into common stock at the fixed conversion price as stated in the contract.

(7) On March 1, 2017, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €1,840 and €460, respectively, with a 2.5% interest per annum and a maturity date of March 1, 2018. The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018. Both Round Enterprises Ltd. And Eardley Holding AG have agreed to amend the maturity date of these promissory notes to follow the same terms of the other convertible loans. Therefore, the maturity date of the promissory notes is amended to be the later of (i) June 30, 2018, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. The amendments were accounted for as modifications in the consolidated financial statements.

(8) On June 1, 2018, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €1,280 and €320 in two tranches, respectively, with a 2.5% interest per annum. The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2019, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(9) On June 15, 2019, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €600 with a 2.5% interest per annum. The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(10) On December 20, 2019, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €600 with a 2.5% interest per annum. The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(11) On June 15, 2020, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €1,100 with a 2.5% interest per annum. The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(12) On December 15, 2020, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €850 with a 2.5% interest per annum. The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(13) On August 15, 2021, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €1,200 with a 2.5% interest per annum. The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(14) On April 30, 2022, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €960 and €240 in two tranches, respectively, with a 2.5% interest per annum. The first tranche of the promissory Notes of €480 and €120, respectively, were provided immediately. The second tranche of the promissory notes of €480 and €120, respectively, has been provided on August 15, 2022, with a 2.5% interest per annum. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2022, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

On April 2, 2020, the Swiss entity, Mymetics SA, received a federal credit line of Chf168 (€156) in relation with the Covid-19 pandemic. This credit line applies for five years and is fully guaranteed by the Swiss Confederation via guaranteed organizations. The interest rate is currently at 0 percent until March 31, 2021. The Swiss Confederation has the right to adjust the interest rate to the market rate. The first revision took place as of April 1, 2021, but no modification was applied. A first amortization installment of €14 is due on October 3, 2022. The next amortization of €14 will be due on March 31, 2023. The entire loan should be fully amortized by September 30, 2027.

Certain of the secured convertible notes have conversion features that should be bifurcated from the debt and recorded at fair value; however, as of September 30, 2022, and December 31, 2021, the probability of the conversion features being exercised was zero. For this reason, the conversion features are not required to be bifurcated from the debt as the fair value is zero at September 30, 2022, and December 31, 2021.

Note 3. Commitments

The facility lease agreement for Epalinges, Switzerland, is automatically renewed month by month with a notice period of three months. The related rent is paid monthly in the amount of €4 and is considered a short-term lease. As the term is less than twelve months, the lease is outside of the scope of ASC 842 and not accounted for on the balance sheet due to the Company’s policy elections.

The facility lease agreement for Leiden, The Netherlands, runs until March 31, 2024, and can be terminated with a six month notice as of September 30, 2023. The related rent is paid monthly in the amount of €9. The Company does not have any other operating lease for its research and development facilities, corporate headquarter, offices and equipment.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

GENERAL

The following discussion and analysis of the results of operations and financial condition of Mymetics Corporation for the periods ended September 30, 2022 and 2021 should be read in conjunction with the Company's audited consolidated financial statements for the year ended December 31, 2021 and related notes and the description of the Company's business and properties included elsewhere herein.

This report contains forward-looking statements that involve risks and uncertainties. The statements contained in this report are not purely historical but are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These forward-looking statements concern matters that involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. Words such as "may," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue", "probably" or similar words are intended to identify forward looking statements, although not all forward-looking statements contain these words.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We are under no duty to update any of the forward-looking statements after the date hereof to conform such statements to actual results or to changes in our expectations.

Readers are urged to carefully review and consider the various disclosures made by us which attempt to advise interested parties of the factors which affect our business, including without limitation disclosures made under the captions "Management Discussion and Analysis of Financial Condition and Results of Operations," "Risk Factors," "Consolidated Financial Statements" and "Notes to Consolidated Financial Statements" included in our annual report on Form 10-K for the year ended December 31, 2021 and, to the extent included therein, our quarterly reports on Form 10-Q filed during fiscal year 2022.

IMPACT OF THE NOVEL CORONAVIRUS

The COVID-19 pandemic has continued to evolve. Although at this date the restrictive measures and impacts are reduced due to the role out of vaccination programs, the extent to which the outbreak impacts our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the emergence of new variants, the duration of the pandemic, travel restrictions and social distancing, business closures or business disruptions and the effectiveness of actions taken in the U.S., Europe, and other countries to contain and treat the disease. As such, it is uncertain as to the full magnitude that the pandemic will have on the Company’s financial condition, liquidity, and future results of operations.

Management has taken measures in-line with the country requirements where we are operational and actively monitoring the impact of this global situation on its financial condition, liquidity, operations, scientific collaborations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022.

CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT

On March 27, 2020, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. The CARES Act includes various income and payroll tax provisions. The Company has analyzed the tax provisions of the CARES Act and determined they have no significant financial impact to the condensed financial statements. The Company has no intention of taking advantage of other benefits but will continue to evaluate the impact on the Company’s financial position.

THREE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

For the three months ended September 30, 2022 and 2021, revenue was €130 and €82, respectively, which was mainly related to the revenue recognized for the work performed under the NIH grant / HIV project in both years.

Costs and expenses increased to €529 for the three months ended September 30, 2022 from €450 (17.6%) for the three months ended September 30, 2021, of which:

	o	Research and development expenses increased to €209 in the current period from €190 (10.0%) in the comparative period of 2021, mainly due to subcontracting services in relation with the NIH grant / HIV project.

	o	General and administrative expenses increased to €320 in the three months ended September 30, 2022 from €260 (23.1%) in the comparative period of 2021, mainly due to consulting fees related to the engagement of consultants that will seek business development opportunities for the Company with the goal of obtaining deals for licensing, financing, and/or acquisition.

Interest expense increased to €703 for the three months ended September 30, 2022 from €688 for the three months ended September 30, 2021 related to an increase in existing loans from related parties.

Foreign exchange revaluation, recorded in Other (income) expense, generated net losses of €230 and €75 during the three months ended September 30, 2022 and 2021, respectively, which is due to the revaluation of existing US$ based loans from related parties and US$ cash position, reflecting the strong US$ in relation to the Euro.

The Company reported a net loss of (€1,345), or (€0.00) per share, for the three months ended September 30, 2022, compared to a net loss of (€1,153), or (€0.00) per share, for the three months ended September 30, 2021.

NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

Revenue was €912 for the nine months ended September 30, 2022, and €375 for the nine months ended September 30, 2021, which was mainly related to the revenue recognized for the work performed under the NIH grant / HIV project in both years.

Costs and expenses increased to €2,170 for the nine months ended September 30, 2022 from €1,580 (37.3%) for the nine months ended September 30, 2021, of which:

	o	Research and development expenses increased to €1,191 in the current period from €752 (58.4%) in the comparative period of 2021, mainly due to the purchase of “influenza inactivated virus” during the first quarter in 2022 in relation with the NIH grant / HIV project.

	o	General and administrative expenses increased to €979 in the nine months ended September 30, 2022 from €828 (18.2%) in the comparative period of 2021, mainly due to service fees related to the engagement as of May 2022 of consultants that will seek business development opportunities for the Company with the goal of obtaining deals for licensing, financing, and/or acquisition.

Foreign exchange revaluation, recorded in Other (income) expense, generated net losses of €496 and €154 during the nine months ended September 30, 2022 and 2021, respectively, which is due to the revaluation of existing US$ based loans from related parties and US$ cash position, reflecting the strong US$ in relation to the Euro.

The Company reported a net loss of (€3,898), or (€0.01) per share, for the nine months ended September 30, 2022, compared to a net loss of (€3,501), or (€0.01) per share, for the nine months ended September 30, 2021.

LIQUIDITY AND CAPITAL RESOURCES

We had cash of €401 at September 30, 2022 compared to €571 at December 31, 2021.

During 2021, our revenue has mainly been generated through the NIH grant / HIV project. For 2022, new significant revenues are not expected unless and until a major licensing agreement or other commercial arrangement is entered into with respect to our technology or new grant financings are awarded.

As of September 30, 2022, we had an accumulated deficit of approximately €102 million, and had net loss of €3,898 in the nine-month period ending on that date. We expect to continue to incur net losses in the future for research, development and activities related to the future licensing of our technologies, and because of the accrual of interest payable on existing loans.

Net cash used from operating activities increased to €1,366 for the nine-month period ended September 30, 2022, compared to €1,259 for the same period in 2021, mainly due to the receivable related to the NIH grant / HIV project incurred during the nine-month period ending September 30, 2022.

Net cash used in investing activities was €2 during the nine-months ended September 30, 2022 and €10 during the same period in 2021, mainly due to new IT equipment in Epalinges in 2022 and new laboratory equipment in Leiden in 2021.

Financing activities provided net cash of 1,200 for the nine-months ended September 30, 2022 and 2021, respectively, related to new promissory notes from our main investors.

Salaries and related payroll costs represent gross salaries for two executives, our CSO of Mymetics BV and seven employees. Under Executive Employment Agreements with our CEO and two CSOs, we pay our executive officers a combined amount of €65 per month.

Our Swiss subsidiary, Mymetics S.A., has, besides the CEO and CSO, two additional employees on its payroll: Director of Finance and Head of Manufacturing and Quality. Mymetics BV has, besides the full time Chief Scientific Officer, two full-time technicians and one part-time assistant.

We intend to continue to incur additional expenditures during the next nine months for additional research and development of our HIV, Covid-19 vaccines and immunotherapy projects, which we will try to seek through collaborations with pharmaceutical companies or with not-for-profit organizations. These expenditures will relate to the continued research and testing of these prototype vaccines and are included in the monthly cash outflow described above.

In the past, we have financed our research and development activities primarily through debt and equity financings from various parties and through license and collaboration agreements and grant agreements.

We anticipate that our normal operations will require approximately €400 additional funding as of December 31, 2022. We will seek to raise the additional capital from equity or debt financings, and grants through donors and potential partnerships with major international pharmaceutical and biotechnology firms. However, there can be no assurance that it will be able to raise additional capital on satisfactory terms, or at all, to finance its operations on the longer term. In the event that we are not able to obtain such additional capital, we will be required to further restrict or even cease our operations.

Monthly fixed and recurring expenses for "Property leases" of €13 represent the monthly lease and maintenance payments to unaffiliated third parties for our offices, of which €4 is related to our executive office located at Route de la Corniche 4, 1066 Epalinges in Switzerland (100 square meters), and €9 related to Bestewil Holding B.V. and its subsidiary Mymetics B.V operating from a similar biotechnology campus near Leiden in the Netherlands, where they occupy 204 square meters.

Included in professional fees are legal fees paid to outside corporate counsel and audit and review fees paid to our independent accountants, and fees paid for investor relations.

Cumulative interest expense of €33,614 has been accrued on all of the Company’s outstanding notes and advances (see detailed table in Note 2 to the financial statements).

RECENT FINANCING ACTIVITIES

During the nine-month period ending September 30, 2022, our principal source of funds has been promissory notes received in a prior quarter from our two main investors and the revenue generated through the NIH grant / HIV project.

We have filed or are in the process of filing several new grant applications with U.S. and European institutions in relation to our virosome based vaccines.

We anticipate using our current funds and those we receive in the future both to meet our working capital needs and for funding the ongoing vaccines pre-clinical research costs for new virosome vaccine.

Management anticipates that our existing capital resources will be sufficient to fund our cash requirements through the next five months. We have cash presently on hand in conjunction with the collection of receivables, based upon our current levels of expenditures and anticipated needs during this period. For 2022, we will need additional funding through future collaborative arrangements, licensing arrangements, and debt and equity financings under Regulation D and Regulation S under the Securities Act of 1933. We do not know whether additional financing will be available on commercially acceptable terms when needed. These conditions raise substantial doubt about our ability to continue as a going concern.

If management cannot raise funds on acceptable terms when needed, we may not be able to successfully commercialize our technologies, take advantage of future opportunities, or respond to unanticipated requirements. If unable to secure such additional financing when needed, we will have to curtail or suspend all or a portion of our business activities and could be required to cease operations entirely. Further, if new equity securities are issued, our shareholders may experience severe dilution of their ownership percentage.

The extent and timing of our future capital requirements will depend primarily upon the rate of our progress in the research and development of our technologies, our ability to enter into a partnership agreement with a major pharmaceutical company, and the results of our present projects and future clinical trials.

OFF-BALANCE SHEET ARRANGEMENTS

None

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

INTEREST RATE RISK

Fluctuations in interest rates may affect the fair value of financial instruments. An increase in market interest rates may increase interest payments and a decrease in market interest rates may decrease interest payments of such financial instruments. We have no debt obligations which are sensitive to interest rate fluctuations as all our notes payable have fixed interest rates, as specified on the individual loan notes.

ITEM 4. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

Under the supervision and with the participation of the Company’s management, including its Chief Executive Officer and Chief Financial Officer the Company conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures, as defined in Rule 13a−15(e) and 15d15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this report. Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer (currently the same person to allow timely decisions regarding required disclosure) concluded as of September 30, 2022, that the Company’s disclosure controls and procedures were not effective because of the material weakness described below.

Management’s Annual Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a15(f) and 15d15(f) under the Exchange Act). Our internal control over financial reporting includes policies and procedures designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles.

Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting as of September 30, 2022, based on the criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting during the quarter ended September 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. No changes of internal control over financial reporting were made in the nine months ended September 30, 2022.

INHERENT LIMITATIONS ON EFFECTIVENESS OF CONTROLS

Our management, Ronald Kempers, who is both CEO and CFO, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the company have been detected.

These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Neither we, nor our wholly owned subsidiaries, Mymetics S.A. and Bestewil Holding B.V., nor its subsidiary Mymetics B.V., are presently involved in any litigation incident to our business.

ITEM 1A. RISK FACTORS

Not Applicable

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

EXHIBIT NUMBER		DESCRIPTION

31.1		Rule 13a-14(a)/15d-14(a) Certification of Chief

31.2		Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer

32		Section 1350 Certification of Chief Executive Officer and Chief Financial Officer

101.INS		Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MYMETICS CORPORATION

Dated: November 14, 2022	By:	/s/ Ronald Kempers
		(Principal Executive, Financial and Accounting Officer)

EX-31.1 2 mymx_ex311.htm CERTIFICATION mymx_ex311.htm

EXHIBIT 31.1

CERTIFICATIONS

CHIEF EXECUTIVE OFFICER I, Ronald Kempers, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Mymetics Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2022	By:	/s/ Ronald Kempers
		Chief Executive Officer

EX-31.2 3 mymx_ex312.htm CERTIFICATION mymx_ex312.htm

EXHIBIT 31.2

CHIEF FINANCIAL OFFICER I, Ronald Kempers, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Mymetics Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2022	By:	/s/ Ronald Kempers
		Chief Financial Officer

EX-32 4 mymx_ex32.htm CERTIFICATION mymx_ex32.htm

EXHIBIT 32

PURSUANT TO 18 U.S.C. 1350

Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Mymetics Corporation, a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:

The Quarterly Report on Form 10-Q for the nine months ended September 30, 2022 (the "Form 10-Q") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 14, 2022	By:	/s/ Ronald Kempers
		Chief Executive Officer / Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as a separate disclosure document.

EX-101.SCH 5 mymx-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - The Company and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - Debt Financing link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - The Company and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - Debt Financing (Tables) link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - The Company and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - Debt Financing (Details) link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - Debt Financing (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - Commitments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 mymx-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address Address Line 3 Entity Address City Or Town Entity Address Country Entity Address Postal Zip Code City Area Code Local Phone Number Security 12g Title Trading Symbol Entity Interactive Data Current CONDENSED CONSOLIDATED BALANCE SHEETS ASSETS Current Assets Cash Accounts receivable Prepaid expenses Total current assets Rent deposit Property and equipment, net of accumulated depreciation of ?483 at September 30, 2022 and ?474 at December 31, 2021 Right-of-Use Asset Goodwill Total [Assets] LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) Current Liabilities Accounts payable Operating Lease Liability Non-convertible notes payable and related accrued interest to related parties Convertible notes payable and related accrued interest to related parties Total current liabilities Long Term Liabilities Debt-Principal Payable to the Federal Financing Bank Operating lease liability1 Total long-term liabilities Total liabilities Commitments and Contingencies (Note 3) Shareholders' Deficit Common stock, U.S. $0.01 par value; 1,200,000,000 shares authorized; issued and outstanding 303,757,622 at September 30, 2022 and at December 31, 2021 Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none-issued or Outstanding Additional paid-in capital Accumulated deficit Accumulated other comprehensive income Total shareholders' deficit Total liabilities and shareholders' deficit Property and equipment, accumulated depreciation Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) Revenue Other Research and development1 Grants Revenue total Expenses Research and development General and administrative Expenses total Operating Loss Interest expense Other (income) expense Loss before income tax provision Income tax provision Net Loss Other comprehensive income Foreign currency translation adjustment [Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax] Comprehensive loss Basic and dilutive earnings per share Weighted-average shares outstanding, basic and diluted CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) Statement [Table] Statement [Line Items] Equity Components [Axis] Common Stock APIC Accumulated Deficit Accumulated Other Comprehensive Income Balance, shares [Shares, Issued] Balance, amount Net loss Translation adjustment Net loss [Net loss] Balance, shares Balance, amount CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Cash Flow from Operating Activities Net loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Adjustments to reconcile net loss to net cash used in operating activities Depreciation Changes in operating assets and liabilities Receivables [Increase (Decrease) in Receivables] Accrued interest on convertible notes payable Accrued interest on non-convertible notes payable Accounts payable [Increase (Decrease) in Accounts Payable] Deferred grant Other [Other] Net cash used in operating activities Cash Flows from Investing Activities Purchase of property and equipment [Payments to Acquire Property, Plant, and Equipment] Net cash used in investing activities Cash Flows from Financing Activities Proceeds from borrowing on-line of credit with federal bank Proceeds from issuance of non-convertible notes Net cash provided by financing activities Effect on foreign exchange rate on cash Net change in cash Cash, beginning of period [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents] Cash, end of period Supplemental Disclosure of Cash Flow Information: Cash paid for taxes [Income Taxes Paid] The Company and Summary of Significant Accounting Policies The Company and Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Debt Financing Debt Financing Debt Disclosure [Text Block] Commitments Commitments Commitments and Contingencies Disclosure [Text Block] BASIS OF PRESENTATION AND GOING CONCERN LEASES IMPACT OF THE NOVEL CORONAVIRUS CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT PRINCIPLES OF CONSOLIDATION NEW ACCOUNTING PRONOUNCEMENT FOREIGN CURRENCY TRANSLATION CASH REVENUE RECOGNITION NIH Option to License Agreement ANERGIS SA RECEIVABLES PROPERTY AND EQUIPMENT IMPAIRMENT OF LONG LIVED ASSETS GOODWILL RESEARCH AND DEVELOPMENT WITHHOLDING TAXES TAXES ON INCOME EARNINGS PER SHARE PREFERRED STOCK ESTIMATES FAIR VALUE MEASUREMENTS FAIR VALUES OF FINANCIAL INSTRUMENTS CONCENTRATIONS RELATED PARTY TRANSACTIONS Convertible notes, loans and contingent liabilities Debt Instrument [Axis] Plan Name [Axis] Financial Instrument [Axis] Stock Option [Member] First Year [Member] Second Year [Member] Third Year [Member] Grant Revenue [Member] Accumulated deficit Current liabilities exceeding current assets Preferred stock shares authorized Potentially shares issuable Potentially shares issuable convertible loans Sub award grant revenue USD Sub award grant revenue euro Sub award project cost USD Sub award project cost euro Basic weighted and diluted Professional fees Carrying amount EX-101.CAL 7 mymx-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 8 mymx-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 9 mymx-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2022	Nov. 11, 2022
Cover [Abstract]
Entity Registrant Name	MYMETICS CORPORATION
Entity Central Index Key	0000927761
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Sep. 30, 2022
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Entity Common Stock Shares Outstanding		303,757,622
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-25132
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	25-1741849
Entity Address Address Line 1	c/o Ernie Stern
Entity Address Address Line 2	1101 Pennsylvania Avenue, N.W
Entity Address Address Line 3	Suite 300
Entity Address City Or Town	Washington D.C.
Entity Address Country	US
Entity Address Postal Zip Code	20004
City Area Code	011
Local Phone Number	41 21 653 4535
Security 12g Title	Common Stock, Par Value $0.01 per share
Trading Symbol	MYMX
Entity Interactive Data Current	Yes

XML 11 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - EUR (€) € in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current Assets
Cash	€ 401	€ 571
Accounts receivable	58	15
Prepaid expenses	138	87
Total current assets	597	673
Rent deposit	10	10
Property and equipment, net of accumulated depreciation of ?483 at September 30, 2022 and ?474 at December 31, 2021	30	39
Right-of-Use Asset	159	239
Goodwill	6,671	6,671
Total	7,467	7,632
Current Liabilities
Accounts payable	48	47
Operating Lease Liability	106	110
Non-convertible notes payable and related accrued interest to related parties	10,151	8,790
Convertible notes payable and related accrued interest to related parties	60,915	58,479
Total current liabilities	71,220	67,426
Long Term Liabilities
Debt-Principal Payable to the Federal Financing Bank	176	162
Operating lease liability1	57	130
Total long-term liabilities	233	292
Total liabilities	71,453	67,718
Commitments and Contingencies (Note 3)	0	0
Shareholders' Deficit
Common stock, U.S. $0.01 par value; 1,200,000,000 shares authorized; issued and outstanding 303,757,622 at September 30, 2022 and at December 31, 2021	2,530	2,530
Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none-issued or Outstanding	0	0
Additional paid-in capital	34,443	34,443
Accumulated deficit	(101,648)	(97,750)
Accumulated other comprehensive income	689	691
Total shareholders' deficit	(63,986)	(60,086)
Total liabilities and shareholders' deficit	€ 7,467	€ 7,632

XML 12 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Parenthetical) - EUR (€) € in Thousands	Sep. 30, 2022	Dec. 31, 2021
CONDENSED CONSOLIDATED BALANCE SHEETS
Property and equipment, accumulated depreciation	€ 483	€ 474
Common stock, par value	€ 0.01	€ 0.01
Common stock, shares authorized	1,200,000,000	1,200,000,000
Common stock, shares issued	303,757,622	303,757,622
Common stock, shares outstanding	303,757,622	303,757,622
Preferred stock, par value	€ 0.01	€ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

XML 13 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - EUR (€) € in Thousands, shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue
Other	€ 0	€ 0	€ 3	€ 0
Research and development1	0	0	0	3
Grants	130	82	909	372
Revenue total	130	82	912	375
Expenses
Research and development	209	190	1,191	752
General and administrative	320	260	979	828
Expenses total	529	450	2,170	1,580
Operating Loss	(399)	(368)	(1,258)	(1,205)
Interest expense	703	688	2,096	2,057
Other (income) expense	243	86	544	186
Loss before income tax provision	(1,345)	(1,142)	(3,898)	(3,448)
Income tax provision	0	(11)	0	(53)
Net Loss	(1,345)	(1,153)	(3,898)	(3,501)
Other comprehensive income
Foreign currency translation adjustment	(7)	(5)	(2)	(12)
Comprehensive loss	€ (1,352)	€ (1,158)	€ (3,900)	€ (3,513)
Basic and dilutive earnings per share	€ (0.00)	€ (0.00)	€ (0.01)	€ (0.01)
Weighted-average shares outstanding, basic and diluted	303,757,622	303,757,622	303,757,622	303,757,622

XML 14 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) - EUR (€) € in Thousands, shares in Thousands	Total	Common Stock	APIC	Accumulated Deficit	Accumulated Other Comprehensive Income
Balance, shares at Dec. 31, 2020		303,757,622
Balance, amount at Dec. 31, 2020	€ (55,352)	€ 2,530	€ 34,443	€ (93,020)	€ 695
Net loss	(1,246)	0	0	(1,246)	0
Translation adjustment	(8)	€ 0	0	0	(8)
Balance, shares at Mar. 31, 2021		303,757,622
Balance, amount at Mar. 31, 2021	(56,606)	€ 2,530	34,443	(94,266)	687
Balance, shares at Dec. 31, 2020		303,757,622
Balance, amount at Dec. 31, 2020	(55,352)	€ 2,530	34,443	(93,020)	695
Net loss	(3,501)
Balance, shares at Sep. 30, 2021		303,757,622
Balance, amount at Sep. 30, 2021	(58,865)	€ 2,530	34,443	(96,521)	683
Balance, shares at Mar. 31, 2021		303,757,622
Balance, amount at Mar. 31, 2021	(56,606)	€ 2,530	34,443	(94,266)	687
Net loss	(1,102)	0	0	(1,102)	0
Translation adjustment	1	€ 0	0	0	1
Balance, shares at Jun. 30, 2021		303,757,622
Balance, amount at Jun. 30, 2021	(57,707)	€ 2,530	34,443	(95,368)	688
Net loss	(1,153)	0	0	(1,153)	0
Translation adjustment	(5)	€ 0	0	0	(5)
Balance, shares at Sep. 30, 2021		303,757,622
Balance, amount at Sep. 30, 2021	(58,865)	€ 2,530	34,443	(96,521)	683
Balance, shares at Dec. 31, 2021		303,757,622
Balance, amount at Dec. 31, 2021	(60,086)	€ 2,530	34,443	(97,750)	691
Net loss	(1,211)	0	0	(1,211)	0
Translation adjustment	7	€ 0	0	0	7
Balance, shares at Mar. 31, 2022		303,757,622
Balance, amount at Mar. 31, 2022	(61,290)	€ 2,530	34,443	(98,961)	698
Balance, shares at Dec. 31, 2021		303,757,622
Balance, amount at Dec. 31, 2021	(60,086)	€ 2,530	34,443	(97,750)	691
Net loss	(3,898)
Balance, shares at Sep. 30, 2022		303,757,622
Balance, amount at Sep. 30, 2022	(63,986)	€ 2,530	34,443	(101,648)	689
Balance, shares at Mar. 31, 2022		303,757,622
Balance, amount at Mar. 31, 2022	(61,290)	€ 2,530	34,443	(98,961)	698
Net loss	(1,342)	0	0	(1,342)	0
Translation adjustment	(2)	€ 0	0	0	(2)
Balance, shares at Jun. 30, 2022		303,757,622
Balance, amount at Jun. 30, 2022	(62,634)	€ 2,530	34,443	(100,303)	696
Net loss	(1,345)
Translation adjustment	(7)	0	0	0	(7)
Net loss	(1,345)	€ 0	0	(1,345)	0
Balance, shares at Sep. 30, 2022		303,757,622
Balance, amount at Sep. 30, 2022	€ (63,986)	€ 2,530	€ 34,443	€ (101,648)	€ 689

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 15 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - EUR (€) € in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flow from Operating Activities
Net loss	€ (3,898)	€ (3,501)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	11	14
Changes in operating assets and liabilities
Receivables	(43)	39
Accrued interest on convertible notes payable	2,436	2,083
Accrued interest on non-convertible notes payable	161	136
Accounts payable	1	0
Deferred grant	0	13
Other	(34)	(43)
Net cash used in operating activities	(1,366)	(1,259)
Cash Flows from Investing Activities
Purchase of property and equipment	(2)	(10)
Net cash used in investing activities	(2)	(10)
Cash Flows from Financing Activities
Proceeds from borrowing on-line of credit with federal bank	0	0
Proceeds from issuance of non-convertible notes	1,200	1,200
Net cash provided by financing activities	1,200	1,200
Effect on foreign exchange rate on cash	(2)	(12)
Net change in cash	(170)	(81)
Cash, beginning of period	571	1,083
Cash, end of period	401	1,002
Supplemental Disclosure of Cash Flow Information:
Cash paid for taxes	€ 0	€ (48)

XML 16 R7.htm IDEA: XBRL DOCUMENT

The Company and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2022

The Company and Summary of Significant Accounting Policies

The Company and Summary of Significant Accounting Policies

Note 1. The Company and Summary of Significant Accounting Policies

BASIS OF PRESENTATION AND GOING CONCERN

The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts.

LEASES

IMPACT OF THE NOVEL CORONAVIRUS

CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.

NEW ACCOUNTING PRONOUNCEMENT

FOREIGN CURRENCY TRANSLATION

CASH

The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts.

REVENUE RECOGNITION

NIH

Option to License Agreement – ANERGIS SA

RECEIVABLES

PROPERTY AND EQUIPMENT

IMPAIRMENT OF LONG-LIVED ASSETS

GOODWILL

RESEARCH AND DEVELOPMENT

Research and development costs are expensed as incurred.

WITHHOLDING TAXES

TAXES ON INCOME

EARNINGS PER SHARE

PREFERRED STOCK

ESTIMATES

FAIR VALUE MEASUREMENTS

Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:

	Level 1-		Quoted prices in active markets for identical assets or liabilities.
	Level 2-		Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3-		Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

FAIR VALUES OF FINANCIAL INSTRUMENTS

CONCENTRATIONS

RELATED PARTY TRANSACTIONS

XML 17 R8.htm IDEA: XBRL DOCUMENT

Debt Financing

9 Months Ended

Sep. 30, 2022

Debt Financing

Debt Financing

Note 2. Debt Financing

The details of the convertible notes and loans are as follows at September 30, 2022:

										Fixed
								Conversion		Rate
Lender	1st-Issue	Principal		Duration			Interest	Price		EUR/USD
Price	Date	Amount		(Note)			Rate	(stated)		Conversion

Eardley Holding A.G. (1)	06/23/2006	€	194		(2	)	10% pa	$	0.10		N/A
Anglo Irish Bank S.A.(3)	10/21/2007	€	500		(2	)	10% pa	$	0.50		1.4090
Round Enterprises Ltd.	12/10/2007	€	1,500		(2	)	10% pa	$	0.50		1.4429
Round Enterprises Ltd.	01/22/2008	€	1,500		(2	)	10% pa	$	0.50		1.4629
Round Enterprises Ltd.	04/25/2008	€	2,000		(2	)	10% pa	$	0.50		1.5889
Round Enterprises Ltd.	06/30/2008	€	1,500		(2	)	10% pa	$	0.50		1.5380
Round Enterprises Ltd.	11/18/2008	€	1,200		(2	)	10% pa	$	0.50		1.2650
Round Enterprises Ltd.	02/09/2009	€	1,500		(2	)	10% pa	$	0.50		1.2940
Round Enterprises Ltd.	06/15/2009	€	5,500		(2,4	)	10% pa	$	0.80		1.4045
Eardley Holding A.G.	06/15/2009	€	100		(2,4	)	10% pa	$	0.80		1.4300
Von Meyenburg	08/03/2009	€	200		(2	)	10% pa	$	0.80		1.4400
Round Enterprises Ltd.	10/13/2009	€	2,000		(2	)	5% pa	$	0.25		1.4854
Round Enterprises Ltd.	12/18/2009	€	2,200		(2	)	5% pa	$	0.25		1.4338
Round Enterprises Ltd.	08/04/2011	€	1,225		(5,6	)	10% pa	$	0.034		N/A
Eardley Holding A.G.	08/04/2011	€	306		(5,6	)	10% pa	$	0.034		N/A
Round Enterprises Ltd.	11/08/2011	€	400		(6	)	10% pa	$	0.034		1.3787
Eardley Holding A.G.	11/08/2011	€	100		(6	)	10% pa	$	0.034		1.3787
Round Enterprises Ltd.	02/10/2012	€	1,000		(6	)	10% pa	$	0.034		1.3260
Eardley Holding A.G.	02/14/2012	€	200		(6	)	10% pa	$	0.034		1.3260
Round Enterprises Ltd.	04/19/2012	€	322		(6	)	10% pa	$	0.034		1.3100
Eardley Holding A.G.	04/19/2012	€	80		(6	)	10% pa	$	0.034		1.3100
Round Enterprises Ltd.	05/04/2012	€	480		(6	)	10% pa	$	0.034		1.3152
Eardley Holding A.G.	05/04/2012	€	120		(6	)	10% pa	$	0.034		1.3152
Round Enterprises Ltd.	09/03/2012	€	200		(6	)	10% pa	$	0.034		1.2576
Eardley Holding A.G.	09/03/2012	€	50		(6	)	10% pa	$	0.034		1.2576
Round Enterprises Ltd.	11/14/2012	€	500		(6	)	10% pa	$	0.034		1.2718
Eardley Holding A.G.	12/06/2012	€	125		(6	)	10% pa	$	0.034		1.3070
Round Enterprises Ltd.	01/16/2013	€	240		(6	)	10% pa	$	0.034		1.3318
Eardley Holding A.G.	01/16/2013	€	60		(6	)	10% pa	$	0.034		1.3318
Round Enterprises Ltd.	03/25/2013	€	400		(6	)	10% pa	$	0.037		1.2915
Eardley Holding A.G.	04/14/2013	€	150		(6	)	10% pa	$	0.034		1.3056
Round Enterprises Ltd.	04/14/2013	€	600		(6	)	10% pa	$	0.034		1.3056
Eardley Holding A.G.	05/15/2013	€	170		(6	)	10% pa	$	0.037		1.2938
Round Enterprises Ltd.	05/15/2013	€	680		(6	)	10% pa	$	0.037		1.2938
Eardley Holding A.G.	06/24/2013	€	60		(6	)	10% pa	$	0.025		1.3340
Round Enterprises Ltd.	06/24/2013	€	240		(6	)	10% pa	$	0.025		1.3340
Eardley Holding A.G.	08/05/2013	€	80		(6	)	10% pa	$	0.018		1.3283
Round Enterprises Ltd.	08/05/2013	€	320		(6	)	10% pa	$	0.018		1.3283
Eardley Holding A.G.	03/01/2017	€	230		(7	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	03/01/2017	€	920		(7	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	10/18/2017	€	230		(7	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	10/18/2017	€	920		(7	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	06/01/2018	€	160		(8	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	06/01/2018	€	640		(8	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	11/10/2018	€	160		(8	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	11/10/2018	€	640		(8	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	06/15/2019	€	120		(9	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	06/15/2019	€	480		(9	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	12/20/2019	€	120		(10	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	12/20/2019	€	480		(10	)	2.5% pa		N/A		N/A
Eardley Holding AG	06/15/2020	€	220		(11	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	06/15/2020	€	880		(11	)	2.5% pa		N/A		N/A
Eardley Holding AG	12/15/2020	€	170		(12	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	12/15/2020	€	680		(12	)	2.5% pa		N/A		N/A
Eardley Holding AG	08/15/2021	€	240		(13	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	08/15/2021	€	960		(13	)	2.5% pa		N/A		N/A
Eardley Holding AG	04/30/2022	€	120		(14	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	04/30/2022	€	480		(14	)	2.5% pa		N/A		N/A
Eardley Holding AG	08/15/2022	€	120		(14	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	08/15/2022	€	480		(14	)	2.5% pa		N/A		N/A
Total Short Term Principal Amounts		€	37,452
Accrued Interest		€	33,614
TOTAL LOANS AND NOTES		€	71,066

(1) Private investment company of Dr. Thomas Staehelin, member of the Board of Directors and of the Audit Committee of the Company. Face value is stated in U.S. dollars at $190.

(2) This maturity date is automatically prolonged for periods of three months, unless called for repayment.

(3) Renamed Hyposwiss Private Bank Genève S.A. and acting on behalf of Round Enterprises Ltd. which is a major shareholder.

(4) The loan is secured against 2/3rds of the IP assets of Bestewil Holding BV and against all property of the Company.

(5) The face values of the loans are stated in U.S. dollars at $1,200 and $300, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

XML 18 R9.htm IDEA: XBRL DOCUMENT

Commitments

9 Months Ended

Sep. 30, 2022

Commitments

Commitments

Note 3. Commitments

XML 19 R10.htm IDEA: XBRL DOCUMENT

The Company and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2022

The Company and Summary of Significant Accounting Policies

BASIS OF PRESENTATION AND GOING CONCERN

The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts.

LEASES

IMPACT OF THE NOVEL CORONAVIRUS

CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.

NEW ACCOUNTING PRONOUNCEMENT

FOREIGN CURRENCY TRANSLATION

CASH

The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts.

REVENUE RECOGNITION

NIH

Option to License Agreement ANERGIS SA

RECEIVABLES

PROPERTY AND EQUIPMENT

IMPAIRMENT OF LONG LIVED ASSETS

GOODWILL

RESEARCH AND DEVELOPMENT

Research and development costs are expensed as incurred.

FAIR VALUE MEASUREMENTS

Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:

	Level 1-		Quoted prices in active markets for identical assets or liabilities.
	Level 2-		Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3-		Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

FAIR VALUES OF FINANCIAL INSTRUMENTS

CONCENTRATIONS

RELATED PARTY TRANSACTIONS

XML 20 R11.htm IDEA: XBRL DOCUMENT

Debt Financing (Tables)

9 Months Ended

Sep. 30, 2022

Debt Financing

Convertible notes, loans and contingent liabilities

										Fixed
								Conversion		Rate
Lender	1st-Issue	Principal		Duration			Interest	Price		EUR/USD
Price	Date	Amount		(Note)			Rate	(stated)		Conversion

Eardley Holding A.G. (1)	06/23/2006	€	194		(2	)	10% pa	$	0.10		N/A
Anglo Irish Bank S.A.(3)	10/21/2007	€	500		(2	)	10% pa	$	0.50		1.4090
Round Enterprises Ltd.	12/10/2007	€	1,500		(2	)	10% pa	$	0.50		1.4429
Round Enterprises Ltd.	01/22/2008	€	1,500		(2	)	10% pa	$	0.50		1.4629
Round Enterprises Ltd.	04/25/2008	€	2,000		(2	)	10% pa	$	0.50		1.5889
Round Enterprises Ltd.	06/30/2008	€	1,500		(2	)	10% pa	$	0.50		1.5380
Round Enterprises Ltd.	11/18/2008	€	1,200		(2	)	10% pa	$	0.50		1.2650
Round Enterprises Ltd.	02/09/2009	€	1,500		(2	)	10% pa	$	0.50		1.2940
Round Enterprises Ltd.	06/15/2009	€	5,500		(2,4	)	10% pa	$	0.80		1.4045
Eardley Holding A.G.	06/15/2009	€	100		(2,4	)	10% pa	$	0.80		1.4300
Von Meyenburg	08/03/2009	€	200		(2	)	10% pa	$	0.80		1.4400
Round Enterprises Ltd.	10/13/2009	€	2,000		(2	)	5% pa	$	0.25		1.4854
Round Enterprises Ltd.	12/18/2009	€	2,200		(2	)	5% pa	$	0.25		1.4338
Round Enterprises Ltd.	08/04/2011	€	1,225		(5,6	)	10% pa	$	0.034		N/A
Eardley Holding A.G.	08/04/2011	€	306		(5,6	)	10% pa	$	0.034		N/A
Round Enterprises Ltd.	11/08/2011	€	400		(6	)	10% pa	$	0.034		1.3787
Eardley Holding A.G.	11/08/2011	€	100		(6	)	10% pa	$	0.034		1.3787
Round Enterprises Ltd.	02/10/2012	€	1,000		(6	)	10% pa	$	0.034		1.3260
Eardley Holding A.G.	02/14/2012	€	200		(6	)	10% pa	$	0.034		1.3260
Round Enterprises Ltd.	04/19/2012	€	322		(6	)	10% pa	$	0.034		1.3100
Eardley Holding A.G.	04/19/2012	€	80		(6	)	10% pa	$	0.034		1.3100
Round Enterprises Ltd.	05/04/2012	€	480		(6	)	10% pa	$	0.034		1.3152
Eardley Holding A.G.	05/04/2012	€	120		(6	)	10% pa	$	0.034		1.3152
Round Enterprises Ltd.	09/03/2012	€	200		(6	)	10% pa	$	0.034		1.2576
Eardley Holding A.G.	09/03/2012	€	50		(6	)	10% pa	$	0.034		1.2576
Round Enterprises Ltd.	11/14/2012	€	500		(6	)	10% pa	$	0.034		1.2718
Eardley Holding A.G.	12/06/2012	€	125		(6	)	10% pa	$	0.034		1.3070
Round Enterprises Ltd.	01/16/2013	€	240		(6	)	10% pa	$	0.034		1.3318
Eardley Holding A.G.	01/16/2013	€	60		(6	)	10% pa	$	0.034		1.3318
Round Enterprises Ltd.	03/25/2013	€	400		(6	)	10% pa	$	0.037		1.2915
Eardley Holding A.G.	04/14/2013	€	150		(6	)	10% pa	$	0.034		1.3056
Round Enterprises Ltd.	04/14/2013	€	600		(6	)	10% pa	$	0.034		1.3056
Eardley Holding A.G.	05/15/2013	€	170		(6	)	10% pa	$	0.037		1.2938
Round Enterprises Ltd.	05/15/2013	€	680		(6	)	10% pa	$	0.037		1.2938
Eardley Holding A.G.	06/24/2013	€	60		(6	)	10% pa	$	0.025		1.3340
Round Enterprises Ltd.	06/24/2013	€	240		(6	)	10% pa	$	0.025		1.3340
Eardley Holding A.G.	08/05/2013	€	80		(6	)	10% pa	$	0.018		1.3283
Round Enterprises Ltd.	08/05/2013	€	320		(6	)	10% pa	$	0.018		1.3283
Eardley Holding A.G.	03/01/2017	€	230		(7	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	03/01/2017	€	920		(7	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	10/18/2017	€	230		(7	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	10/18/2017	€	920		(7	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	06/01/2018	€	160		(8	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	06/01/2018	€	640		(8	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	11/10/2018	€	160		(8	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	11/10/2018	€	640		(8	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	06/15/2019	€	120		(9	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	06/15/2019	€	480		(9	)	2.5% pa		N/A		N/A
Eardley Holding A.G.	12/20/2019	€	120		(10	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	12/20/2019	€	480		(10	)	2.5% pa		N/A		N/A
Eardley Holding AG	06/15/2020	€	220		(11	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	06/15/2020	€	880		(11	)	2.5% pa		N/A		N/A
Eardley Holding AG	12/15/2020	€	170		(12	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	12/15/2020	€	680		(12	)	2.5% pa		N/A		N/A
Eardley Holding AG	08/15/2021	€	240		(13	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	08/15/2021	€	960		(13	)	2.5% pa		N/A		N/A
Eardley Holding AG	04/30/2022	€	120		(14	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	04/30/2022	€	480		(14	)	2.5% pa		N/A		N/A
Eardley Holding AG	08/15/2022	€	120		(14	)	2.5% pa		N/A		N/A
Round Enterprises Ltd.	08/15/2022	€	480		(14	)	2.5% pa		N/A		N/A
Total Short Term Principal Amounts		€	37,452
Accrued Interest		€	33,614
TOTAL LOANS AND NOTES		€	71,066

XML 21 R12.htm IDEA: XBRL DOCUMENT

The Company and Summary of Significant Accounting Policies (Details Narrative) - EUR (€)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Accumulated deficit	€ (101,648,000)		€ (101,648,000)		€ (97,750,000)
Current liabilities exceeding current assets	€ 70,623		€ 70,623
Preferred stock shares authorized	5,000,000		5,000,000		5,000,000
Potentially shares issuable			793,630,391	757,030,713
Potentially shares issuable convertible loans	767,880,391			731,280,713
Sub award grant revenue USD			€ 971
Sub award grant revenue euro			909
Sub award project cost USD			2,796
Sub award project cost euro			€ 2,511
Basic weighted and diluted	303,757,622	303,757,622	303,757,622	303,757,622
Professional fees	€ 10	€ 6	€ 40	€ 17
Carrying amount			€ 70,603
Budget description			The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fourth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616.
Grant allocated description			The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in May 2022 for the fourth year.
Grant Revenue [Member]
Concentration risk percentage			100.00%	99.00%
First Year [Member]
Sub award project cost USD			€ 547
Sub award project cost euro			542
Second Year [Member]
Sub award project cost USD			870
Third Year [Member]
Sub award project cost USD			€ 1,078
Stock Option [Member]
Potentially shares issuable			25,750,000	25,750,000

XML 22 R13.htm IDEA: XBRL DOCUMENT

Debt Financing (Details) € / shares in Units, € in Thousands	9 Months Ended
	Sep. 30, 2022 EUR (€) € / shares
Total short term principal amounts	€ 37,452
Accrued interest	33,614
Total loans and notes	€ 71,066
Note 1 [Member]
Issuance date	06/23/2006
Interest rate	10.00%
Principal amount	€ 194
Conversion price \| € / shares	€ 0.10
Note 2 [Member]
Issuance date	10/21/2007
Interest rate	10.00%
Principal amount	€ 500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.4090
Note 3 [Member]
Issuance date	12/10/2007
Interest rate	10.00%
Principal amount	€ 1,500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.4429
Note 4 [Member]
Issuance date	01/22/2008
Interest rate	10.00%
Principal amount	€ 1,500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.4629
Note 5 [Member]
Issuance date	04/25/2008
Interest rate	10.00%
Principal amount	€ 2,000
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.5889
Note 6 [Member]
Issuance date	06/30/2008
Interest rate	10.00%
Principal amount	€ 1,500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.5380
Note 7 [Member]
Issuance date	11/18/2008
Interest rate	10.00%
Principal amount	€ 1,200
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.2650
Note 8 [Member]
Issuance date	02/09/2009
Interest rate	10.00%
Principal amount	€ 1,500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.2940
Note 9 [Member]
Issuance date	06/15/2009
Interest rate	10.00%
Principal amount	€ 5,500
Conversion price \| € / shares	€ 0.80
Fixed rate conversion	1.4045
Note 10 [Member]
Issuance date	06/15/2009
Interest rate	10.00%
Principal amount	€ 100
Conversion price \| € / shares	€ 0.80
Fixed rate conversion	1.4300
Note 11 [Member]
Issuance date	08/03/2009
Interest rate	10.00%
Principal amount	€ 200
Conversion price \| € / shares	€ 0.80
Fixed rate conversion	1.4400
Note 12 [Member]
Issuance date	10/13/2009
Interest rate	5.00%
Principal amount	€ 2,000
Conversion price \| € / shares	€ 0.25
Fixed rate conversion	1.4854
Note 13 [Member]
Issuance date	12/18/2009
Interest rate	5.00%
Principal amount	€ 2,200
Conversion price \| € / shares	€ 0.25
Fixed rate conversion	1.4338
Note 14 [Member]
Issuance date	08/04/2011
Interest rate	10.00%
Principal amount	€ 1,225
Conversion price \| € / shares	€ 0.034
Note 15 [Member]
Issuance date	08/04/2011
Interest rate	10.00%
Principal amount	€ 306
Conversion price \| € / shares	€ 0.034
Note 16 [Member]
Issuance date	11/08/2011
Interest rate	10.00%
Principal amount	€ 400
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3787
Note 17 [Member]
Issuance date	11/08/2011
Interest rate	10.00%
Principal amount	€ 100
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3787
Note 18 [Member]
Issuance date	02/10/2012
Interest rate	10.00%
Principal amount	€ 1,000
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3260
Note 19 [Member]
Issuance date	02/14/2012
Interest rate	10.00%
Principal amount	€ 200
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3260
Note 20 [Member]
Issuance date	04/19/2012
Interest rate	10.00%
Principal amount	€ 322
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3100
Note 21 [Member]
Issuance date	04/19/2012
Interest rate	10.00%
Principal amount	€ 80
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3100
Note 22 [Member]
Issuance date	05/04/2012
Interest rate	10.00%
Principal amount	€ 480
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3152
Note 23 [Member]
Issuance date	05/04/2012
Interest rate	10.00%
Principal amount	€ 120
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3152
Note 24 [Member]
Issuance date	09/03/2012
Interest rate	10.00%
Principal amount	€ 200
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.2576
Note 25 [Member]
Issuance date	09/03/2012
Interest rate	10.00%
Principal amount	€ 50
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.2576
Note 26 [Member]
Issuance date	11/14/2012
Interest rate	10.00%
Principal amount	€ 500
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.2718
Note 27 [Member]
Issuance date	12/06/2012
Interest rate	10.00%
Principal amount	€ 125
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3070
Note 28 [Member]
Issuance date	01/16/2013
Interest rate	10.00%
Principal amount	€ 240
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3318
Note 29 [Member]
Issuance date	01/16/2013
Interest rate	10.00%
Principal amount	€ 60
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3318
Note 30 [Member]
Issuance date	03/25/2013
Interest rate	10.00%
Principal amount	€ 400
Conversion price \| € / shares	€ 0.037
Fixed rate conversion	1.2915
Note 31 [Member]
Issuance date	04/14/2013
Interest rate	10.00%
Principal amount	€ 150
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3056
Note 32 [Member]
Issuance date	04/14/2013
Interest rate	10.00%
Principal amount	€ 600
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3056
Note 33 [Member]
Issuance date	05/15/2013
Interest rate	10.00%
Principal amount	€ 170
Conversion price \| € / shares	€ 0.037
Fixed rate conversion	1.2938
Note 34 [Member]
Issuance date	05/15/2013
Interest rate	10.00%
Principal amount	€ 680
Conversion price \| € / shares	€ 0.037
Fixed rate conversion	1.2938
Note 35 [Member]
Issuance date	06/24/2013
Interest rate	10.00%
Principal amount	€ 60
Conversion price \| € / shares	€ 0.025
Fixed rate conversion	1.3340
Note 36 [Member]
Issuance date	06/24/2013
Interest rate	10.00%
Principal amount	€ 240
Conversion price \| € / shares	€ 0.025
Fixed rate conversion	1.3340
Note 37 [Member]
Issuance date	08/05/2013
Interest rate	10.00%
Principal amount	€ 80
Conversion price \| € / shares	€ 0.018
Fixed rate conversion	1.3283
Note 38 [Member]
Issuance date	08/05/2013
Interest rate	10.00%
Principal amount	€ 320
Conversion price \| € / shares	€ 0.018
Fixed rate conversion	1.3283
Note 39 [Member]
Issuance date	03/01/2017
Interest rate	2.50%
Principal amount	€ 230
Note 40 [Member]
Issuance date	03/01/2017
Interest rate	2.50%
Principal amount	€ 920
Note 41 [Member]
Issuance date	10/18/2017
Interest rate	2.50%
Principal amount	€ 230
Note 42 [Member]
Issuance date	10/18/2017
Interest rate	2.50%
Principal amount	€ 920
Note 43 [Member]
Issuance date	06/01/2018
Interest rate	2.50%
Principal amount	€ 160
Note 44 [Member]
Issuance date	06/01/2018
Interest rate	2.50%
Principal amount	€ 640
Note 45 [Member]
Issuance date	11/10/2018
Interest rate	2.50%
Principal amount	€ 160
Note 46 [Member]
Issuance date	11/10/2018
Interest rate	2.50%
Principal amount	€ 640
Note 47 [Member]
Issuance date	06/15/2019
Interest rate	2.50%
Principal amount	€ 120
Note 48 [Member]
Issuance date	06/15/2019
Interest rate	2.50%
Principal amount	€ 480
Note 49 [Member]
Issuance date	12/20/2019
Interest rate	2.50%
Principal amount	€ 120
Note 50 [Member]
Issuance date	12/20/2019
Interest rate	2.50%
Principal amount	€ 480
Note 51 [Member]
Issuance date	06/15/2020
Interest rate	2.50%
Principal amount	€ 220
Note 52 [Member]
Issuance date	06/15/2020
Interest rate	2.50%
Principal amount	€ 880
Note 53 [Member]
Issuance date	12/15/2020
Interest rate	2.50%
Principal amount	€ 170
Note 54 [Member]
Issuance date	12/15/2020
Interest rate	2.50%
Principal amount	€ 680
Note 55 [Member]
Issuance date	08/15/2021
Interest rate	2.50%
Principal amount	€ 240
Note 56 [Member]
Issuance date	08/15/2021
Interest rate	2.50%
Principal amount	€ 960
Note 57 [Member]
Issuance date	04/30/2022
Interest rate	2.50%
Principal amount	€ 120
Note 58 [Member]
Issuance date	04/30/2022
Interest rate	2.50%
Principal amount	€ 480
Note 59 [Member]
Issuance date	08/15/2022
Interest rate	2.50%
Principal amount	€ 120
Note 60 [Member]
Issuance date	08/15/2022
Interest rate	2.50%
Principal amount	€ 480

XML 23 R14.htm IDEA: XBRL DOCUMENT

Debt Financing (Details Narrative) - EUR (€) € in Thousands					1 Months Ended				9 Months Ended
Debt Financing (Details Narrative) - EUR (€) € in Thousands	Aug. 15, 2021	Dec. 15, 2020	Jun. 01, 2018	Mar. 01, 2017	Apr. 30, 2022	Jun. 15, 2020	Dec. 20, 2019	Jun. 15, 2019	Sep. 30, 2022	Apr. 02, 2020
Debt Financing
Amortization installment description									A first amortization installment of €14 is due on October 3, 2022. The next amortization of €14 will be due on March 31, 2023. The entire loan should be fully amortized by September 30, 2027.
Debt instruments description	The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.	The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.	The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum.	The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018.	The first tranche of the promissory Notes of €480 and €120, respectively, were provided immediately. The second tranche of the promissory notes of €480 and €120, respectively, has been provided on August 15, 2022, with a 2.5% interest per annum.	The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.	The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.	The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.
Received from federal credit line										€ 156
Interest rate	2.50%	2.50%	2.50%	2.50%	2.50%	2.50%	2.50%	2.50%
Promissory Notes Tranches 1			€ 1,280
Promissory Notes Tranches 2			€ 320
Promissory Notes	€ 1,200	€ 850				€ 1,100	€ 600	€ 600
Debt instrument face value 1									€ 190
Promissory Notes Round Enterprises					€ 960
Promissory Notes Eardley Holding AG					€ 240
Debt instrument face value 2									1,200
Debt instrument face value 3									€ 300
Description of conversion price									reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above.
Promissory Notes 1				€ 1,840
Promissory Notes 2				€ 460
Total loans and notes									€ 71,066

XML 24 R15.htm IDEA: XBRL DOCUMENT

Commitments (Details Narrative) € in Thousands	9 Months Ended
Commitments (Details Narrative) € in Thousands	Sep. 30, 2022 EUR (€)
Switzerlands [Member]
Rent paid per month	€ 4
Netherlands [Member]
Rent paid per month	€ 9

XML 25 mymx_10q_htm.xml IDEA: XBRL DOCUMENT 0000927761 2022-01-01 2022-09-30 0000927761 mymx:NetharlandsMember 2022-01-01 2022-09-30 0000927761 mymx:SwitzerlandsMember 2022-01-01 2022-09-30 0000927761 2022-04-30 0000927761 2021-08-15 0000927761 2020-12-15 0000927761 2020-06-15 0000927761 2019-12-20 0000927761 2019-06-15 0000927761 2018-06-01 0000927761 2017-03-01 0000927761 2020-04-02 0000927761 2022-04-01 2022-04-30 0000927761 2021-08-01 2021-08-15 0000927761 2020-12-01 2020-12-15 0000927761 2020-06-01 2020-06-15 0000927761 2019-12-01 2019-12-20 0000927761 2019-06-01 2019-06-15 0000927761 2018-05-26 2018-06-01 0000927761 2017-02-26 2017-03-01 0000927761 mymx:NoteSixtyMember 2022-09-30 0000927761 mymx:NoteFiftyNineMember 2022-09-30 0000927761 mymx:NoteFiftyEightMember 2022-09-30 0000927761 mymx:NoteFifySevenMember 2022-09-30 0000927761 mymx:NoteFifySixMember 2022-09-30 0000927761 mymx:NoteFiftyFiveMember 2022-09-30 0000927761 mymx:NoteFiftyFourMember 2022-09-30 0000927761 mymx:NoteFiftyThreeMember 2022-09-30 0000927761 mymx:NoteFiftyTwoMember 2022-09-30 0000927761 mymx:NoteFiftyOneMember 2022-09-30 0000927761 mymx:NoteFiftyMember 2022-09-30 0000927761 mymx:NoteFortyNineMember 2022-09-30 0000927761 mymx:NoteFortyEightMember 2022-09-30 0000927761 mymx:NoteFortySevenMember 2022-09-30 0000927761 mymx:NoteFortySixMember 2022-09-30 0000927761 mymx:NoteFortyFiveMember 2022-09-30 0000927761 mymx:NoteFortyFourMember 2022-09-30 0000927761 mymx:NoteFortyThreeMember 2022-09-30 0000927761 mymx:NoteFortyTwoMember 2022-09-30 0000927761 mymx:NoteFortyOneMember 2022-09-30 0000927761 mymx:NoteFortyMember 2022-09-30 0000927761 mymx:NoteThrityNineMember 2022-09-30 0000927761 mymx:NoteThrityEightMember 2022-09-30 0000927761 mymx:NoteThritySevenMember 2022-09-30 0000927761 mymx:NoteThritySixMember 2022-09-30 0000927761 mymx:NoteThrityFiveMember 2022-09-30 0000927761 mymx:NoteThrityFourMember 2022-09-30 0000927761 mymx:NoteThrityThreeMember 2022-09-30 0000927761 mymx:NoteThrityTwoMember 2022-09-30 0000927761 mymx:NoteThrityOneMember 2022-09-30 0000927761 mymx:NoteThrityMember 2022-09-30 0000927761 mymx:NoteTwentyNineMember 2022-09-30 0000927761 mymx:NoteTwentyEightMember 2022-09-30 0000927761 mymx:NoteTwentySevenMember 2022-09-30 0000927761 mymx:NoteTwentySixMember 2022-09-30 0000927761 mymx:NoteTwentyFiveMember 2022-09-30 0000927761 mymx:NoteTwentyFourMember 2022-09-30 0000927761 mymx:NoteTwentyThreeMember 2022-09-30 0000927761 mymx:NoteTwentyTwoMember 2022-09-30 0000927761 mymx:NoteTwentyOneMember 2022-09-30 0000927761 mymx:NoteTwentyMember 2022-09-30 0000927761 mymx:NoteNinteenMember 2022-09-30 0000927761 mymx:NoteEighteenMember 2022-09-30 0000927761 mymx:NoteSeventeenMember 2022-09-30 0000927761 mymx:NoteSixteenMember 2022-09-30 0000927761 mymx:NoteFiftteenMember 2022-09-30 0000927761 mymx:NoteFourteenMember 2022-09-30 0000927761 mymx:NoteThirteenMember 2022-09-30 0000927761 mymx:NoteTwevleMember 2022-09-30 0000927761 mymx:NoteElevenMember 2022-09-30 0000927761 mymx:NoteTenMember 2022-09-30 0000927761 mymx:NoteNineMember 2022-09-30 0000927761 mymx:NoteEightMember 2022-09-30 0000927761 mymx:NoteSevenMember 2022-09-30 0000927761 mymx:NoteSixMember 2022-09-30 0000927761 mymx:NoteFiveMember 2022-09-30 0000927761 mymx:NoteFourMember 2022-09-30 0000927761 mymx:NoteThreeMember 2022-09-30 0000927761 mymx:NoteTwoMember 2022-09-30 0000927761 mymx:NoteOneMember 2022-09-30 0000927761 mymx:NoteSixtyMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiftyNineMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiftyEightMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFifySevenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFifySixMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiftyFiveMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiftyFourMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiftyThreeMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiftyTwoMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiftyOneMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiftyMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortyNineMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortyEightMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortySevenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortySixMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortyFiveMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortyFourMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortyThreeMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortyTwoMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortyOneMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFortyMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThrityNineMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThrityEightMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThritySevenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThritySixMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThrityFiveMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThrityFourMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThrityThreeMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThrityTwoMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThrityOneMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThrityMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentyNineMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentyEightMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentySevenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentySixMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentyFiveMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentyFourMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentyThreeMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentyTwoMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentyOneMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwentyMember 2022-01-01 2022-09-30 0000927761 mymx:NoteNinteenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteEighteenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteSeventeenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteSixteenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiftteenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFourteenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThirteenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwevleMember 2022-01-01 2022-09-30 0000927761 mymx:NoteElevenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteNineMember 2022-01-01 2022-09-30 0000927761 mymx:NoteEightMember 2022-01-01 2022-09-30 0000927761 mymx:NoteSevenMember 2022-01-01 2022-09-30 0000927761 mymx:NoteSixMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFiveMember 2022-01-01 2022-09-30 0000927761 mymx:NoteFourMember 2022-01-01 2022-09-30 0000927761 mymx:NoteThreeMember 2022-01-01 2022-09-30 0000927761 mymx:NoteTwoMember 2022-01-01 2022-09-30 0000927761 mymx:NoteOneMember 2022-01-01 2022-09-30 0000927761 mymx:GrantRevenueMember 2021-01-01 2021-09-30 0000927761 mymx:GrantRevenueMember 2022-01-01 2022-09-30 0000927761 mymx:ThirdYearMember 2022-01-01 2022-09-30 0000927761 mymx:SecondYearMember 2022-01-01 2022-09-30 0000927761 mymx:FirstYearMember 2022-01-01 2022-09-30 0000927761 mymx:StockOptionsMember 2021-01-01 2021-09-30 0000927761 mymx:StockOptionsMember 2022-01-01 2022-09-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000927761 us-gaap:RetainedEarningsMember 2022-09-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000927761 us-gaap:CommonStockMember 2022-09-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000927761 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000927761 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000927761 2022-06-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000927761 us-gaap:RetainedEarningsMember 2022-06-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000927761 us-gaap:CommonStockMember 2022-06-30 0000927761 2022-04-01 2022-06-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000927761 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000927761 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000927761 2022-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000927761 us-gaap:RetainedEarningsMember 2022-03-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000927761 us-gaap:CommonStockMember 2022-03-31 0000927761 2022-01-01 2022-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000927761 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000927761 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000927761 us-gaap:RetainedEarningsMember 2021-12-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000927761 us-gaap:CommonStockMember 2021-12-31 0000927761 2021-09-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000927761 us-gaap:RetainedEarningsMember 2021-09-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000927761 us-gaap:CommonStockMember 2021-09-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000927761 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000927761 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000927761 2021-06-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000927761 us-gaap:RetainedEarningsMember 2021-06-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000927761 us-gaap:CommonStockMember 2021-06-30 0000927761 2021-04-01 2021-06-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0000927761 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000927761 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000927761 2021-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000927761 us-gaap:RetainedEarningsMember 2021-03-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000927761 us-gaap:CommonStockMember 2021-03-31 0000927761 2021-01-01 2021-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000927761 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000927761 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000927761 2020-12-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000927761 us-gaap:RetainedEarningsMember 2020-12-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000927761 us-gaap:CommonStockMember 2020-12-31 0000927761 2021-01-01 2021-09-30 0000927761 2021-07-01 2021-09-30 0000927761 2022-07-01 2022-09-30 0000927761 2021-12-31 0000927761 2022-09-30 0000927761 2022-11-11 iso4217:EUR iso4217:USD shares iso4217:EUR shares pure 0000927761 false --12-31 Q3 2022

0.01

1200000000

303757622

0.01

5000000

303757622 303757622 10-Q true 2022-09-30 false 000-25132 MYMETICS CORPORATION DE 25-1741849 c/o Ernie Stern 1101 Pennsylvania Avenue, N.W Suite 300 Washington D.C. US 20004 011 41 21 653 4535 Common Stock, Par Value $0.01 per share MYMX Yes Yes Non-accelerated Filer true false false 303757622

401000

571000

58000

15000

138000

87000

597000

673000

10000

483000

474000

30000

39000

159000

239000

6671000

7467000

7632000

48000

47000

106000

110000

10151000

8790000

60915000

58479000

71220000

67426000

176000

162000

57000

130000

233000

292000

71453000

67718000

0.01

1200000000

303757622

2530000

0.01

5000000

34443000

-101648000

-97750000

689000

691000

-63986000

-60086000

7467000

7632000

3000

130000 82000 909000 372000

130000

82000

912000

375000

209000

190000

1191000

752000

320000

260000

979000

828000

529000

450000

2170000

1580000

-399000

-368000

-1258000

-1205000

703000

688000

2096000

2057000

243000

86000

544000

186000

-1345000

-1142000

-3898000

-3448000

0 -11000 0 -53000

-1345000

-1153000

-3898000

-3501000

7000

5000

2000

12000

-1352000

-1158000

-3900000

-3513000

-0.00 -0.00 -0.01 -0.01 303757622000 303757622000 303757622000 303757622000

303757622000

2530000

34443000

-93020000

695000

-55352000

-1246000

0 0 0 -8000 -8000

303757622000

2530000

34443000

-94266000

687000

-56606000

-1102000

0 0 0 1000 1000

303757622000

2530000

34443000

-95368000

688000

-57707000

-1153000

0 0 0 -5000 -5000

303757622000

2530000

34443000

-96521000

683000

-58865000

303757622000

2530000

34443000

-97750000

691000

-60086000

-1211000

0 0 0 7000 7000

303757622000

2530000

34443000

-98961000

698000

-61290000

-1342000

0 0 0 -2000 -2000

303757622000

2530000

34443000

-100303000

696000

-62634000

0 0 -1345000 0 -1345000 0 0 0 -7000 -7000

303757622000

2530000

34443000

-101648000

689000

-63986000

3898000

3501000

11000

14000

43000

-39000

2436000

2083000

161000 136000

1000

13000

-34000 -43000

-1366000

-1259000

2000

10000

-2000

-10000

1200000

-2000

-12000

-170000

-81000

571000

1083000

401000

1002000

48000

Note 1. The Company and Summary of Significant Accounting Policies BASIS OF PRESENTATION AND GOING CONCERN The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts. The accompanying interim period condensed consolidated financial statements of Mymetics Corporation (the "Company") set forth herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such SEC rules and regulations. The interim period condensed consolidated financial statements should be read together with the audited financial statements and the accompanying notes included in the Company's latest annual report on Form 10-K for the fiscal year ended December 31, 2021. The accompanying financial statements of the Company are unaudited. However, in the opinion of the Company, the unaudited condensed consolidated financial statements contained herein contain all adjustments necessary to present a fair statement of the results of the interim periods presented. All adjustments made during the three and nine-month period ending September 30, 2022 were of a normal and recurring nature. The Company was created for the purpose of engaging in vaccine research and development. Its main research efforts in the beginning have been concentrated in the prevention and treatment of the AIDS virus and malaria. The Company has established a network which enables it to work with education centers, research centers, pharmaceutical laboratories and biotechnology companies. Besides the HIV and malaria vaccine candidates, the Company additionally has generated preclinical data for the following vaccines: Herpes Simplex and Respiratory Syncytial Virus (“RSV”), neither of which is currently being developed. The company also has clinical data for an intranasal influenza vaccine for the elderly which has finished a Phase I clinical trial and is currently on hold. As of September 30, 2022, the Company is working on several research projects for immunotherapy in the field oncology and for some infectious diseases with academic partners. Since April 2020, the Company has additionally started to work on the development of an intranasal virosome-based vaccine to prevent Covid-19, the disease caused by the SARS-CoV-2 virus. For the Covid-19 vaccine candidates, the Company is collaborating with leading academic institutions, such as Baylor College of Medicine in Texas, the Amsterdam Medical Center (AMC) of the University of Amsterdam in the Netherlands and the University Hospital in Bern, Switzerland. As of September 30, 2022, the Company was engaged in the pre-clinical testing of some of its vaccine candidates, but a commercially viable product is not expected for several more years. However, the Company generated some revenue through collaboration and grant agreements. These consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced negative cash flows from operations and significant losses since inception resulting in an accumulated deficit of €101,648 at September 30, 2022. Further, the Company’s current liabilities exceed its current assets by €70,623 as of September 30, 2022, and there is no assurance that cash will become available to pay current liabilities in the near term. Management is seeking additional financing but there can be no assurance that management will be successful in any of those efforts. These conditions raise substantial doubt about our ability to continue as a going concern within one year from the issuance of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. LEASES Effective January 1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use ("ROU") asset and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease, the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding right-of- use ("ROU") asset. Lease liabilities represent the present value of our future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company’s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.IMPACT OF THE NOVEL CORONAVIRUS On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The COVID-19 pandemic has continued to evolve. Although at this date the restrictive measures and impacts are reduced due to the role out of vaccination programs, the extent to which the outbreak impacts our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, emergence of new variants, the duration of the pandemic, travel restrictions and social distancing, business closures or business disruptions and the effectiveness of actions taken in the U.S., Europe, and other countries to contain and treat the disease. As such, it is uncertain as to the full magnitude that the pandemic will have on the Company’s financial condition, liquidity, and future results of operations. Management has taken measures in-line with the country requirements where we are operating, and we are actively monitoring the global situation on its financial condition, liquidity, operations, scientific collaborations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022. The Company is dependent on its workforce to deliver and advance its research. Developments such as physical distancing and working from home directives have and will continue to impact the Company’s ability to deploy its workforce effectively. While restrictions are being lifted across the world, prolonged workforce disruptions may negatively impact future revenues for the remainder of fiscal year 2022 and the Company’s overall liquidity. The Company is dependent on its partners in certain projects, such as the University of Louisiana at Lafayette (“ULL”) for the NIH funded project to maintain the agreed timelines and execute their tasks. Developments such as social distancing and shelter-in-place directives and lock-down directives have and will continue to impact the Company’s ability to execute on project plans and research objectives effectively. While expected to be temporary, prolonged disruptions in collaboration projects may negatively impact funding for the fiscal year 2022 and the Company’s overall liquidity. Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it may have a material adverse effect on the Company’s results of future operations, financial position, and liquidity for the fiscal year 2022. CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT On March 27, 2020, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. The CARES Act includes various income and payroll tax provisions. The Company has analyzed the tax provisions of the CARES Act and determined they have no significant financial impact to the condensed financial statements. The Company has no intention of taking advantage of other benefits provided by the CARES Act but will continue to evaluate the impact on the Company’s financial position. PRINCIPLES OF CONSOLIDATION The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.NEW ACCOUNTING PRONOUNCEMENT In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. Specifically, ASU 2020-06 simplifies accounting for the issuance of convertible instruments by removing major separation models required under current GAAP. In addition, the ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share (EPS) calculation in certain areas. ASU 2020-06 will be effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, beginning in fiscal years which begin after December 15, 2020. The FASB has specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluating the impact of the pending adoption of this new standard on its consolidated financial statements. FOREIGN CURRENCY TRANSLATION The Company translates non-Euro assets and liabilities of its subsidiaries at the rate of exchange at the balance sheet date. Revenues and expenses are translated at the average rate of exchange throughout the period. Unrealized gains or losses from these translations are reported as a separate component of comprehensive income. Transaction gains or losses are included in foreign exchange (gain) loss in the consolidated statements of comprehensive loss. The translation adjustments do not recognize the effect of income tax because the Company expects to reinvest the amounts indefinitely in operations. The Company's reporting currency is the Euro because substantially all of the Company's activities are conducted in Europe. CASH The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts. REVENUE RECOGNITION Effective January 1, 2018, the Company adopted Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers, using the modified retrospective method and there was no impact to financial position and results of operations as a result of the adoption. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under Topic 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Overall, adoption of the new standard did not result in an adjustment to amounts previously reported in our consolidated financial statements and there were no other significant changes impacting the timing or measurement of our revenue or our business processes and controls. The Company has concluded that government grants are not within the scope of Topic 606, as they do not meet the definition of a contract with a “customer”. The Company concluded the definition of a contract with a “customer” was not met as the counterparty to the government grants has not contracted to obtain goods or services and thus the contracts are not considered to have commercial substance. Government grants provide the Company with payments for certain types of expenditures related to research and development activities over a contractually defined period. Revenue from government grants is recognized in the period during which the related costs are incurred, provided that the applicable conditions under the government contracts have been met. NIH On April 29, 2019, the National Institutes of Health (“NIH”) awarded the Company and Texas Biomedical Research Institute (“Texas Biomed”) a five-year grant for the project called “Cold Chain-independent, Needle-free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels” (“NIH Grant”). The project started on May 1, 2019 and is planned for five years. It was initially co-led by Texas Biomed, but due to the move of Dr. Ruth Ruprecht, the Co-Principal Investigator, to the University of Louisiana at Lafayette (“ULL”) at the end of 2019, ULL has become the co-lead with Mymetics for this project. The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fourth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616.The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in May 2022 for the fourth year. The cost incurred and granted under the sub-award with Texas Biomed for the period of May to December 2019 was US$547 (€542). The sub-award contract between ULL and the Company for the period of January 2020 to April 2021, was signed for a total budget of US$870 and US$1,078 for the period May 2021 to April 2022. The total grant revenue incurred as of today is US$2,796 (€2,511), of which US$971 (€909) has been incurred during the nine-months ended September 30, 2022. First results are expected to be reported in 2023. The project has the objective to prepare the Company’s promising HIV-1 vaccine candidate for clinical trials, by first executing a non-human primate (“NHP”) study, where the test subjects will be receiving Mymetics’ virosome based HIV-1 vaccine candidate by several intra-muscular and intra-nasal applications, followed by rectal challenges. As of September 30, 2022, Mymetics has successfully produced five sets of virosome based vaccines and the NHPs have received two intramuscular vaccinations and three intranasal vaccinations in two different studies. The vaccinations were well tolerated. These studies are ongoing. The vaccine is created to induce protective mucosal antibodies acting as a frontline defense against sexual HIV transmission. This awarded grant from the NIH will allow the Company to continue some of the developments that were achieved during the European Horizon 2020 project. In February 2022, Mymetics announced the publication of results in Frontiers in Immunology title: “Cooperation between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques against Mucosal SHIV challenges”. Option to License Agreement – ANERGIS SA In April 2018 Mymetics engaged in a Research and Option to License Agreement with Anergis SA. Under the agreement, a mice proof-of-concept immunogenicity study evaluated the effects of the Bet v 1 COPs (Anergis’ proprietary birch pollen allergy peptides) using the five subcutaneous injection schedules used in former AllerT clinical trials. The development of AllerT (Bet v 1 COPs plus aluminum hydroxide) was discontinued by Anergis in 2017 following completion of a Phase 2 clinical trial showing evidence of sensitization to the peptides and a 7% reduction in seasonal allergy symptoms vs placebo (p=0.0047). In the mice study, AllerT was compared to Bet v 1 COPs linked to Mymetics’ virosomes (the “Bet v 1 COP-virosomes”). In December 2018 Anergis and Mymetics reported that the administration of AllerT led to the development of Bet v 1 specific IgEs (p<0.001) associated with a more pronounced TH2 than TH1 response. In contrast, in the mice receiving the Bet v 1 COP-virosomes, no development of Bet v 1 specific IgEs were observed (p<0.001 vs AllerT). With the same dose of Bet v 1 COPs, there was a strong boost of immunogenicity with a TH1 antibody response, which was a hundred times greater than with aluminum hydroxide (p<0.001). The Bet v 1 COP-virosomes were well tolerated. The success criteria were met and Anergis had a time limited option to enter into an exclusive license agreement with Mymetics for the use of virosomes in the field of allergies. In October 2019, Mymetics announced that Anergis SA started a new study with Stallergenes Greer SA whereby the COP-Virosomes were tested in the therapeutic mouse model of birch allergy in comparison with positive controls, i.e., birch allergen and birch pollen extract. This model has been confirmed as having predictive value towards the future clinical efficacy of new AIT treatment candidates. In May 2020, Mymetics announced the results of the study with Stallergenes Greer, a worldwide leader in allergen immunotherapy (AIT) and Anergis, a leader in ultra-fast AIT research and development. The results showed that a treatment with COP-virosomes was able to cure allergic asthma in birch pollen sensitized mice and that the COP-virosomes were significantly superior to the COP or the virosome alone, confirming the synergy between COP and virosomes to foster an improved second-generation AIT treatment. In January 2021, following the two successful studies with its virosome platform, Mymetics announced the acceptance of its joint publication in the scientific journal Clinical & Experimental Allergy with Stallergenes Greer SA and Anergis SA, with the title: Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice. As of February 1, 2021, Anergis SA has entered into liquidation since it was not able to raise sufficient funds to continue to operate. As of June 17, 2022, Anergis SA has entered into bankruptcy proceedings.RECEIVABLES Receivables are stated at their outstanding principal balances. Management reviews the collectability of receivables on a periodic basis and determines the appropriate amount of any allowance. There was no allowance necessary at September 30, 2022 or December 31, 2021. The Company writes off receivables to the allowance when management determines that a receivable is not collectible. The Company may retain a security interest in the products sold. PROPERTY AND EQUIPMENT Property and equipment is recorded at cost and is depreciated over its estimated useful life on straight-line basis from the date placed in service. Estimated useful lives are usually taken as three years. IMPAIRMENT OF LONG-LIVED ASSETS Long-lived assets, which include property and equipment, are assessed for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The impairment testing involves comparing the carrying amount to the forecasted undiscounted future cash flows generated by that asset. In the event the carrying value of the assets exceeds the undiscounted future cash flows generated by that asset and the carrying value is not considered recoverable, impairment exists. An impairment loss is measured as the excess of the asset’s carrying value over its fair value, calculated using a discounted future cash flow method. An impairment loss would be recognized in net income (loss) in the period that the impairment occurs. GOODWILL Goodwill represents the excess of purchase price over the value assigned to the net tangible and identifiable intangible assets of a business acquired. The Company typically performs its annual goodwill impairment test effective as of April 1 of each year, unless events or circumstances indicate impairment may have occurred before that time. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than it’s carrying amount. After assessing qualitative factors, the Company determined that no further testing was necessary. If further testing was necessary, the Company would determine the fair value of each reporting unit and compare the fair value to the reporting unit’s carrying amount. The Company has one reporting unit. RESEARCH AND DEVELOPMENT Research and development costs are expensed as incurred. WITHHOLDING TAXES On March 10, 2021, the Swiss Federal tax administration conducted a withholding tax audit on Mymetics SA’s financial statements for the years 2015 to 2019. At the end of the tax audit, the tax inspector concluded that a portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA could be considered as a hidden dividend distribution and therefore subject to Swiss withholding tax. The tax inspector encouraged the Company to file the relevant Swiss withholding tax forms to benefit from the double tax treaty between Switzerland and the United States. All required documentation has been sent, assessed and approved by the Swiss Federal tax administration. The portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA is considered as a hidden dividend distribution and therefore subject to Swiss withholding tax at a reduced tax rate of 5% and based on the double tax treaty in force between Switzerland and the United State of America. All required tax declaration forms have been filed and the related withholding tax amounts have been accounted for as of December 31, 2021. TAXES ON INCOME The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than enactments of changes in the tax laws or rates. The Company reports a liability, if any, for unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return. Estimated interest and penalties, if any, are recorded as a component of interest expense and other expense, respectively. The Company has not recorded any liabilities for uncertain tax positions or any related interest and penalties at September 30, 2022 nor December 31, 2021. The Company’s United States tax returns are open to audit for the years ended December 31, 2015 to 2019. The returns for the Swiss subsidiary, Mymetics S.A., are open to audit for the year ended December 31, 2021. The returns for the Netherlands subsidiaries, Bestewil B.V. and Mymetics B.V., are open to audit for the year ended December 31, 2021.EARNINGS PER SHARE Basic earnings per share is computed by dividing net income or loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. Diluted earnings per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. For the periods ended September 30, 2022 and 2021, options and convertible debt were not included in the computation of diluted earnings per share because their effect would be anti-dilutive due to net losses incurred under the treasury stock method. For the three and nine months ended September 30, 2022, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 793,630,391 at September 30, 2022 includes 767,880,391 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees. For the three and nine months ended September 30, 2021, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 757,030,713 at September 30, 2021 includes 731,280,713 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees. PREFERRED STOCK The Company has authorized 5,000,000 shares of preferred stock that may be issued in several series with varying dividend, conversion and voting rights. No preferred shares are issued or outstanding at September 30, 2022 or December 31, 2021. ESTIMATES The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. FAIR VALUE MEASUREMENTS Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: <table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:left;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"> </td><td style="width:6%;">Level 1-</td><td> </td><td>Quoted prices in active markets for identical assets or liabilities.</td></tr><tr style="height:15px"><td> </td><td>Level 2-</td><td> </td><td>Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</td></tr><tr style="height:15px"><td> </td><td>Level 3-</td><td> </td><td>Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</td></tr></tbody></table> FAIR VALUES OF FINANCIAL INSTRUMENTS The Company generally has the following financial instruments: cash, receivables, accounts payable, and notes payable. The carrying value of cash, accounts receivable, and accounts payable, approximates their fair value based on the short-term nature of these financial instruments. Management believes the fair value of the note’s payable is reflecting the actual value reported for these instruments. CONCENTRATIONS The Company derived 100% and 99% of grant revenue for the nine-month periods ended September 30, 2022 and 2021, from one grantor, respectively. For the period ended December 31, 2021, the Company derived 95% of grant revenue from one partner. RELATED PARTY TRANSACTIONS Mr. Ernest M. Stern, the Company’s outside U.S. counsel, is both a director of the Company and is a partner in Culhane Meadows PLLC, the firm retained as legal counsel by the Company. The Company incurred professional fees to the counsel's law firms totaling €10 and €6 for the three months ended September 30, 2022 and 2021 respectively; and €40 and €17 for the nine months ended September 30, 2022 and 2021, respectively. Two of the Company’s major shareholders have granted secured convertible notes and short-term convertible notes and promissory notes, which have a total carrying amount of €70,603 including interest due as of September 30, 2022. Conversion prices on the Euro-denominated convertible debt have been fixed to a fixed Euro/US dollar exchange rate.

The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts. The accompanying interim period condensed consolidated financial statements of Mymetics Corporation (the "Company") set forth herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such SEC rules and regulations. The interim period condensed consolidated financial statements should be read together with the audited financial statements and the accompanying notes included in the Company's latest annual report on Form 10-K for the fiscal year ended December 31, 2021. The accompanying financial statements of the Company are unaudited. However, in the opinion of the Company, the unaudited condensed consolidated financial statements contained herein contain all adjustments necessary to present a fair statement of the results of the interim periods presented. All adjustments made during the three and nine-month period ending September 30, 2022 were of a normal and recurring nature. The Company was created for the purpose of engaging in vaccine research and development. Its main research efforts in the beginning have been concentrated in the prevention and treatment of the AIDS virus and malaria. The Company has established a network which enables it to work with education centers, research centers, pharmaceutical laboratories and biotechnology companies. Besides the HIV and malaria vaccine candidates, the Company additionally has generated preclinical data for the following vaccines: Herpes Simplex and Respiratory Syncytial Virus (“RSV”), neither of which is currently being developed. The company also has clinical data for an intranasal influenza vaccine for the elderly which has finished a Phase I clinical trial and is currently on hold. As of September 30, 2022, the Company is working on several research projects for immunotherapy in the field oncology and for some infectious diseases with academic partners. Since April 2020, the Company has additionally started to work on the development of an intranasal virosome-based vaccine to prevent Covid-19, the disease caused by the SARS-CoV-2 virus. For the Covid-19 vaccine candidates, the Company is collaborating with leading academic institutions, such as Baylor College of Medicine in Texas, the Amsterdam Medical Center (AMC) of the University of Amsterdam in the Netherlands and the University Hospital in Bern, Switzerland. As of September 30, 2022, the Company was engaged in the pre-clinical testing of some of its vaccine candidates, but a commercially viable product is not expected for several more years. However, the Company generated some revenue through collaboration and grant agreements. These consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced negative cash flows from operations and significant losses since inception resulting in an accumulated deficit of €101,648 at September 30, 2022. Further, the Company’s current liabilities exceed its current assets by €70,623 as of September 30, 2022, and there is no assurance that cash will become available to pay current liabilities in the near term. Management is seeking additional financing but there can be no assurance that management will be successful in any of those efforts. These conditions raise substantial doubt about our ability to continue as a going concern within one year from the issuance of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

-101648000

70623

Effective January 1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use ("ROU") asset and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease, the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding right-of- use ("ROU") asset. Lease liabilities represent the present value of our future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company’s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The COVID-19 pandemic has continued to evolve. Although at this date the restrictive measures and impacts are reduced due to the role out of vaccination programs, the extent to which the outbreak impacts our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, emergence of new variants, the duration of the pandemic, travel restrictions and social distancing, business closures or business disruptions and the effectiveness of actions taken in the U.S., Europe, and other countries to contain and treat the disease. As such, it is uncertain as to the full magnitude that the pandemic will have on the Company’s financial condition, liquidity, and future results of operations. Management has taken measures in-line with the country requirements where we are operating, and we are actively monitoring the global situation on its financial condition, liquidity, operations, scientific collaborations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022. The Company is dependent on its workforce to deliver and advance its research. Developments such as physical distancing and working from home directives have and will continue to impact the Company’s ability to deploy its workforce effectively. While restrictions are being lifted across the world, prolonged workforce disruptions may negatively impact future revenues for the remainder of fiscal year 2022 and the Company’s overall liquidity. The Company is dependent on its partners in certain projects, such as the University of Louisiana at Lafayette (“ULL”) for the NIH funded project to maintain the agreed timelines and execute their tasks. Developments such as social distancing and shelter-in-place directives and lock-down directives have and will continue to impact the Company’s ability to execute on project plans and research objectives effectively. While expected to be temporary, prolonged disruptions in collaboration projects may negatively impact funding for the fiscal year 2022 and the Company’s overall liquidity. Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it may have a material adverse effect on the Company’s results of future operations, financial position, and liquidity for the fiscal year 2022. On March 27, 2020, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. The CARES Act includes various income and payroll tax provisions. The Company has analyzed the tax provisions of the CARES Act and determined they have no significant financial impact to the condensed financial statements. The Company has no intention of taking advantage of other benefits provided by the CARES Act but will continue to evaluate the impact on the Company’s financial position.

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. Specifically, ASU 2020-06 simplifies accounting for the issuance of convertible instruments by removing major separation models required under current GAAP. In addition, the ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share (EPS) calculation in certain areas. ASU 2020-06 will be effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, beginning in fiscal years which begin after December 15, 2020. The FASB has specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluating the impact of the pending adoption of this new standard on its consolidated financial statements.

The Company translates non-Euro assets and liabilities of its subsidiaries at the rate of exchange at the balance sheet date. Revenues and expenses are translated at the average rate of exchange throughout the period. Unrealized gains or losses from these translations are reported as a separate component of comprehensive income. Transaction gains or losses are included in foreign exchange (gain) loss in the consolidated statements of comprehensive loss. The translation adjustments do not recognize the effect of income tax because the Company expects to reinvest the amounts indefinitely in operations. The Company's reporting currency is the Euro because substantially all of the Company's activities are conducted in Europe.

The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts.

Effective January 1, 2018, the Company adopted Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers, using the modified retrospective method and there was no impact to financial position and results of operations as a result of the adoption. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under Topic 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Overall, adoption of the new standard did not result in an adjustment to amounts previously reported in our consolidated financial statements and there were no other significant changes impacting the timing or measurement of our revenue or our business processes and controls. The Company has concluded that government grants are not within the scope of Topic 606, as they do not meet the definition of a contract with a “customer”. The Company concluded the definition of a contract with a “customer” was not met as the counterparty to the government grants has not contracted to obtain goods or services and thus the contracts are not considered to have commercial substance. Government grants provide the Company with payments for certain types of expenditures related to research and development activities over a contractually defined period. Revenue from government grants is recognized in the period during which the related costs are incurred, provided that the applicable conditions under the government contracts have been met.

On April 29, 2019, the National Institutes of Health (“NIH”) awarded the Company and Texas Biomedical Research Institute (“Texas Biomed”) a five-year grant for the project called “Cold Chain-independent, Needle-free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels” (“NIH Grant”). The project started on May 1, 2019 and is planned for five years. It was initially co-led by Texas Biomed, but due to the move of Dr. Ruth Ruprecht, the Co-Principal Investigator, to the University of Louisiana at Lafayette (“ULL”) at the end of 2019, ULL has become the co-lead with Mymetics for this project. The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fourth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616.The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in May 2022 for the fourth year. The cost incurred and granted under the sub-award with Texas Biomed for the period of May to December 2019 was US$547 (€542). The sub-award contract between ULL and the Company for the period of January 2020 to April 2021, was signed for a total budget of US$870 and US$1,078 for the period May 2021 to April 2022. The total grant revenue incurred as of today is US$2,796 (€2,511), of which US$971 (€909) has been incurred during the nine-months ended September 30, 2022. First results are expected to be reported in 2023. The project has the objective to prepare the Company’s promising HIV-1 vaccine candidate for clinical trials, by first executing a non-human primate (“NHP”) study, where the test subjects will be receiving Mymetics’ virosome based HIV-1 vaccine candidate by several intra-muscular and intra-nasal applications, followed by rectal challenges. As of September 30, 2022, Mymetics has successfully produced five sets of virosome based vaccines and the NHPs have received two intramuscular vaccinations and three intranasal vaccinations in two different studies. The vaccinations were well tolerated. These studies are ongoing. The vaccine is created to induce protective mucosal antibodies acting as a frontline defense against sexual HIV transmission. This awarded grant from the NIH will allow the Company to continue some of the developments that were achieved during the European Horizon 2020 project. In February 2022, Mymetics announced the publication of results in Frontiers in Immunology title: “Cooperation between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques against Mucosal SHIV challenges”. The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fourth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616. The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in May 2022 for the fourth year. 547 542 870 1078 2796 2511 971 909 In April 2018 Mymetics engaged in a Research and Option to License Agreement with Anergis SA. Under the agreement, a mice proof-of-concept immunogenicity study evaluated the effects of the Bet v 1 COPs (Anergis’ proprietary birch pollen allergy peptides) using the five subcutaneous injection schedules used in former AllerT clinical trials. The development of AllerT (Bet v 1 COPs plus aluminum hydroxide) was discontinued by Anergis in 2017 following completion of a Phase 2 clinical trial showing evidence of sensitization to the peptides and a 7% reduction in seasonal allergy symptoms vs placebo (p=0.0047). In the mice study, AllerT was compared to Bet v 1 COPs linked to Mymetics’ virosomes (the “Bet v 1 COP-virosomes”). In December 2018 Anergis and Mymetics reported that the administration of AllerT led to the development of Bet v 1 specific IgEs (p<0.001) associated with a more pronounced TH2 than TH1 response. In contrast, in the mice receiving the Bet v 1 COP-virosomes, no development of Bet v 1 specific IgEs were observed (p<0.001 vs AllerT). With the same dose of Bet v 1 COPs, there was a strong boost of immunogenicity with a TH1 antibody response, which was a hundred times greater than with aluminum hydroxide (p<0.001). The Bet v 1 COP-virosomes were well tolerated. The success criteria were met and Anergis had a time limited option to enter into an exclusive license agreement with Mymetics for the use of virosomes in the field of allergies. In October 2019, Mymetics announced that Anergis SA started a new study with Stallergenes Greer SA whereby the COP-Virosomes were tested in the therapeutic mouse model of birch allergy in comparison with positive controls, i.e., birch allergen and birch pollen extract. This model has been confirmed as having predictive value towards the future clinical efficacy of new AIT treatment candidates. In May 2020, Mymetics announced the results of the study with Stallergenes Greer, a worldwide leader in allergen immunotherapy (AIT) and Anergis, a leader in ultra-fast AIT research and development. The results showed that a treatment with COP-virosomes was able to cure allergic asthma in birch pollen sensitized mice and that the COP-virosomes were significantly superior to the COP or the virosome alone, confirming the synergy between COP and virosomes to foster an improved second-generation AIT treatment. In January 2021, following the two successful studies with its virosome platform, Mymetics announced the acceptance of its joint publication in the scientific journal Clinical & Experimental Allergy with Stallergenes Greer SA and Anergis SA, with the title: Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice. As of February 1, 2021, Anergis SA has entered into liquidation since it was not able to raise sufficient funds to continue to operate. As of June 17, 2022, Anergis SA has entered into bankruptcy proceedings.

Receivables are stated at their outstanding principal balances. Management reviews the collectability of receivables on a periodic basis and determines the appropriate amount of any allowance. There was no allowance necessary at September 30, 2022 or December 31, 2021. The Company writes off receivables to the allowance when management determines that a receivable is not collectible. The Company may retain a security interest in the products sold.

Property and equipment is recorded at cost and is depreciated over its estimated useful life on straight-line basis from the date placed in service. Estimated useful lives are usually taken as three years.

Long-lived assets, which include property and equipment, are assessed for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The impairment testing involves comparing the carrying amount to the forecasted undiscounted future cash flows generated by that asset. In the event the carrying value of the assets exceeds the undiscounted future cash flows generated by that asset and the carrying value is not considered recoverable, impairment exists. An impairment loss is measured as the excess of the asset’s carrying value over its fair value, calculated using a discounted future cash flow method. An impairment loss would be recognized in net income (loss) in the period that the impairment occurs.

Goodwill represents the excess of purchase price over the value assigned to the net tangible and identifiable intangible assets of a business acquired. The Company typically performs its annual goodwill impairment test effective as of April 1 of each year, unless events or circumstances indicate impairment may have occurred before that time. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than it’s carrying amount. After assessing qualitative factors, the Company determined that no further testing was necessary. If further testing was necessary, the Company would determine the fair value of each reporting unit and compare the fair value to the reporting unit’s carrying amount. The Company has one reporting unit.

Research and development costs are expensed as incurred.

On March 10, 2021, the Swiss Federal tax administration conducted a withholding tax audit on Mymetics SA’s financial statements for the years 2015 to 2019. At the end of the tax audit, the tax inspector concluded that a portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA could be considered as a hidden dividend distribution and therefore subject to Swiss withholding tax. The tax inspector encouraged the Company to file the relevant Swiss withholding tax forms to benefit from the double tax treaty between Switzerland and the United States. All required documentation has been sent, assessed and approved by the Swiss Federal tax administration. The portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA is considered as a hidden dividend distribution and therefore subject to Swiss withholding tax at a reduced tax rate of 5% and based on the double tax treaty in force between Switzerland and the United State of America. All required tax declaration forms have been filed and the related withholding tax amounts have been accounted for as of December 31, 2021.

The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than enactments of changes in the tax laws or rates. The Company reports a liability, if any, for unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return. Estimated interest and penalties, if any, are recorded as a component of interest expense and other expense, respectively. The Company has not recorded any liabilities for uncertain tax positions or any related interest and penalties at September 30, 2022 nor December 31, 2021. The Company’s United States tax returns are open to audit for the years ended December 31, 2015 to 2019. The returns for the Swiss subsidiary, Mymetics S.A., are open to audit for the year ended December 31, 2021. The returns for the Netherlands subsidiaries, Bestewil B.V. and Mymetics B.V., are open to audit for the year ended December 31, 2021.

Basic earnings per share is computed by dividing net income or loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. Diluted earnings per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. For the periods ended September 30, 2022 and 2021, options and convertible debt were not included in the computation of diluted earnings per share because their effect would be anti-dilutive due to net losses incurred under the treasury stock method. For the three and nine months ended September 30, 2022, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 793,630,391 at September 30, 2022 includes 767,880,391 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees. For the three and nine months ended September 30, 2021, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 757,030,713 at September 30, 2021 includes 731,280,713 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees.

303757622

793630391

767880391

25750000

303757622

757030713

731280713

25750000

The Company has authorized 5,000,000 shares of preferred stock that may be issued in several series with varying dividend, conversion and voting rights. No preferred shares are issued or outstanding at September 30, 2022 or December 31, 2021.

5000000

The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: <table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:left;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"> </td><td style="width:6%;">Level 1-</td><td> </td><td>Quoted prices in active markets for identical assets or liabilities.</td></tr><tr style="height:15px"><td> </td><td>Level 2-</td><td> </td><td>Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</td></tr><tr style="height:15px"><td> </td><td>Level 3-</td><td> </td><td>Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</td></tr></tbody></table>

The Company generally has the following financial instruments: cash, receivables, accounts payable, and notes payable. The carrying value of cash, accounts receivable, and accounts payable, approximates their fair value based on the short-term nature of these financial instruments. Management believes the fair value of the note’s payable is reflecting the actual value reported for these instruments.

The Company derived 100% and 99% of grant revenue for the nine-month periods ended September 30, 2022 and 2021, from one grantor, respectively. For the period ended December 31, 2021, the Company derived 95% of grant revenue from one partner.

1 0.99 Mr. Ernest M. Stern, the Company’s outside U.S. counsel, is both a director of the Company and is a partner in Culhane Meadows PLLC, the firm retained as legal counsel by the Company. The Company incurred professional fees to the counsel's law firms totaling €10 and €6 for the three months ended September 30, 2022 and 2021 respectively; and €40 and €17 for the nine months ended September 30, 2022 and 2021, respectively. Two of the Company’s major shareholders have granted secured convertible notes and short-term convertible notes and promissory notes, which have a total carrying amount of €70,603 including interest due as of September 30, 2022. Conversion prices on the Euro-denominated convertible debt have been fixed to a fixed Euro/US dollar exchange rate.

70603

Note 2. Debt Financing Certain principal shareholders have granted the Company secured convertible notes (in accordance with the Uniform Commercial Code in the State of Delaware), short term convertible notes and other short-term notes, which have a total carrying value of €71,066 including interest due to date. Interest incurred on these notes since inception has been added to the principal amounts. The details of the convertible notes and loans are as follows at September 30, 2022: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Fixed</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Conversion</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Rate</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="vertical-align:bottom;">Lender</td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;">1st-Issue</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Principal</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Duration</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;">Interest</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Price</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">EUR/USD</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;">Price</td><td style="white-space: nowrap;"> </td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Date</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Amount</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">(Note)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Rate</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">(stated)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Conversion</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G. (1)</td><td style="width:1%;white-space: nowrap;"> </td><td>06/23/2006</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">194</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.10</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Anglo Irish Bank S.A.(3)</td><td style="width:1%;white-space: nowrap;"> </td><td>10/21/2007</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4090</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/10/2007</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4429</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>01/22/2008</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4629</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/25/2008</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.5889</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/30/2008</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.5380</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/18/2008</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2650</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>02/09/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2940</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4045</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4300</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Von Meyenburg</td><td style="width:1%;white-space: nowrap;"> </td><td>08/03/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4400</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>10/13/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4854</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/18/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4338</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/04/2011</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,225</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5,6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/04/2011</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">306</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5,6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/08/2011</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">400</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3787</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/08/2011</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3787</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>02/10/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3260</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>02/14/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3260</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/19/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">322</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3100</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/19/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3100</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>05/04/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">480</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3152</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>05/04/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3152</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>09/03/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2576</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>09/03/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2576</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/14/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2718</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/06/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">125</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3070</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>01/16/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">240</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3318</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>01/16/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">60</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3318</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>03/25/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">400</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.037</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2915</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/14/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3056</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/14/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">600</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3056</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>05/15/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">170</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.037</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2938</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>05/15/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">680</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.037</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2938</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/24/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">60</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.025</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3340</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/24/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">240</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.025</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3340</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/05/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3283</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/05/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">320</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3283</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>03/01/2017</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">230</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>03/01/2017</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">920</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>10/18/2017</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">230</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>10/18/2017</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">920</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/01/2018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">160</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/01/2018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">640</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/10/2018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">160</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/10/2018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">640</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(9</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">480</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(9</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/20/2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(10</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/20/2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">480</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(10</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">220</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(11</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">880</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(11</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>12/15/2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">170</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(12</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/15/2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">680</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(12</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>08/15/2021</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">240</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(13</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/15/2021</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">960</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(13</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>04/30/2022</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/30/2022</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">480</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>08/15/2022</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/15/2022</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">480</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Total Short Term Principal Amounts</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37,452</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Accrued Interest</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">33,614</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">TOTAL LOANS AND NOTES</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">71,066</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table>(1) Private investment company of Dr. Thomas Staehelin, member of the Board of Directors and of the Audit Committee of the Company. Face value is stated in U.S. dollars at $190. (2) This maturity date is automatically prolonged for periods of three months, unless called for repayment. (3) Renamed Hyposwiss Private Bank Genève S.A. and acting on behalf of Round Enterprises Ltd. which is a major shareholder. (4) The loan is secured against 2/3rds of the IP assets of Bestewil Holding BV and against all property of the Company. (5) The face values of the loans are stated in U.S. dollars at $1,200 and $300, respectively. (6) This maturity date is automatically prolonged for periods of three months, unless called for repayment. The conversion price per share is determined by the lower of (i) reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above. The convertible note holder has the right to convert at any time prior to the maturity date, at the convertible note holder’s option, prior to the repayment of the outstanding balance under the note by the Company, to convert the unpaid outstanding principal balance and accrued interest, in whole or in part, into common stock at the fixed conversion price as stated in the contract. (7) On March 1, 2017, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €1,840 and €460, respectively, with a 2.5% interest per annum and a maturity date of March 1, 2018. The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018. Both Round Enterprises Ltd. And Eardley Holding AG have agreed to amend the maturity date of these promissory notes to follow the same terms of the other convertible loans. Therefore, the maturity date of the promissory notes is amended to be the later of (i) June 30, 2018, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. The amendments were accounted for as modifications in the consolidated financial statements. (8) On June 1, 2018, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €1,280 and €320 in two tranches, respectively, with a 2.5% interest per annum. The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2019, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (9) On June 15, 2019, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €600 with a 2.5% interest per annum. The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (10) On December 20, 2019, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €600 with a 2.5% interest per annum. The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.(11) On June 15, 2020, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €1,100 with a 2.5% interest per annum. The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (12) On December 15, 2020, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €850 with a 2.5% interest per annum. The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (13) On August 15, 2021, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €1,200 with a 2.5% interest per annum. The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (14) On April 30, 2022, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €960 and €240 in two tranches, respectively, with a 2.5% interest per annum. The first tranche of the promissory Notes of €480 and €120, respectively, were provided immediately. The second tranche of the promissory notes of €480 and €120, respectively, has been provided on August 15, 2022, with a 2.5% interest per annum. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2022, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. On April 2, 2020, the Swiss entity, Mymetics SA, received a federal credit line of Chf168 (€156) in relation with the Covid-19 pandemic. This credit line applies for five years and is fully guaranteed by the Swiss Confederation via guaranteed organizations. The interest rate is currently at 0 percent until March 31, 2021. The Swiss Confederation has the right to adjust the interest rate to the market rate. The first revision took place as of April 1, 2021, but no modification was applied. A first amortization installment of €14 is due on October 3, 2022. The next amortization of €14 will be due on March 31, 2023. The entire loan should be fully amortized by September 30, 2027. Certain of the secured convertible notes have conversion features that should be bifurcated from the debt and recorded at fair value; however, as of September 30, 2022, and December 31, 2021, the probability of the conversion features being exercised was zero. For this reason, the conversion features are not required to be bifurcated from the debt as the fair value is zero at September 30, 2022, and December 31, 2021.

71066000

<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Fixed</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Conversion</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Rate</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="vertical-align:bottom;">Lender</td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;">1st-Issue</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Principal</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Duration</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;">Interest</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Price</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">EUR/USD</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;">Price</td><td style="white-space: nowrap;"> </td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Date</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Amount</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">(Note)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Rate</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">(stated)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Conversion</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G. (1)</td><td style="width:1%;white-space: nowrap;"> </td><td>06/23/2006</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">194</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.10</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Anglo Irish Bank S.A.(3)</td><td style="width:1%;white-space: nowrap;"> </td><td>10/21/2007</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4090</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/10/2007</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4429</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>01/22/2008</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4629</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/25/2008</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.5889</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/30/2008</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.5380</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/18/2008</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2650</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>02/09/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2940</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4045</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4300</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Von Meyenburg</td><td style="width:1%;white-space: nowrap;"> </td><td>08/03/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4400</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>10/13/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4854</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/18/2009</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4338</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/04/2011</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,225</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5,6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/04/2011</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">306</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5,6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/08/2011</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">400</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3787</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/08/2011</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3787</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>02/10/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3260</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>02/14/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3260</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/19/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">322</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3100</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/19/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3100</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>05/04/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">480</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3152</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>05/04/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3152</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>09/03/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2576</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>09/03/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2576</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/14/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2718</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/06/2012</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">125</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3070</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>01/16/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">240</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3318</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>01/16/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">60</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3318</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>03/25/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">400</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.037</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2915</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/14/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3056</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/14/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">600</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.034</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3056</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>05/15/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">170</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.037</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2938</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>05/15/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">680</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.037</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2938</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/24/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">60</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.025</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3340</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/24/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">240</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.025</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3340</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/05/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3283</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/05/2013</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">320</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>10% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3283</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>03/01/2017</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">230</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>03/01/2017</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">920</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>10/18/2017</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">230</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>10/18/2017</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">920</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/01/2018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">160</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/01/2018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">640</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/10/2018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">160</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>11/10/2018</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">640</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(9</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">480</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(9</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/20/2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(10</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/20/2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">480</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(10</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">220</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(11</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>06/15/2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">880</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(11</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>12/15/2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">170</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(12</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>12/15/2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">680</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(12</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>08/15/2021</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">240</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(13</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/15/2021</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">960</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(13</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>04/30/2022</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>04/30/2022</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">480</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Eardley Holding AG</td><td style="width:1%;white-space: nowrap;"> </td><td>08/15/2022</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">120</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;white-space: nowrap;"> </td><td>08/15/2022</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">480</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td>2.5% pa</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Total Short Term Principal Amounts</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37,452</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Accrued Interest</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">33,614</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">TOTAL LOANS AND NOTES</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">€</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">71,066</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table>

06/23/2006

194000

0.10

10/21/2007

500000

0.10

0.50

1.4090

12/10/2007

1500000

0.10

0.50

1.4429

01/22/2008

1500000

0.10

0.50

1.4629

04/25/2008

2000000

0.10

0.50

1.5889

06/30/2008

1500000

0.10

0.50

1.5380

11/18/2008

1200000

0.10

0.50

1.2650

02/09/2009

1500000

0.10

0.50

1.2940

06/15/2009

5500000

0.10

0.80

1.4045

06/15/2009

100000

0.10

0.80

1.4300

08/03/2009

200000

0.10

0.80

1.4400

10/13/2009

2000000

0.05

0.25

1.4854

12/18/2009

2200000

0.05

0.25

1.4338

08/04/2011

1225000

0.10

0.034

08/04/2011

306000

0.10

0.034

11/08/2011

400000

0.10

0.034

1.3787

11/08/2011

100000

0.10

0.034

1.3787

02/10/2012

1000000

0.10

0.034

1.3260

02/14/2012

200000

0.10

0.034

1.3260

04/19/2012

322000

0.10

0.034

1.3100

04/19/2012

80000

0.10

0.034

1.3100

05/04/2012

480000

0.10

0.034

1.3152

05/04/2012

120000

0.10

0.034

1.3152

09/03/2012

200000

0.10

0.034

1.2576

09/03/2012

50000

0.10

0.034

1.2576

11/14/2012

500000

0.10

0.034

1.2718

12/06/2012

125000

0.10

0.034

1.3070

01/16/2013

240000

0.10

0.034

1.3318

01/16/2013

60000

0.10

0.034

1.3318

03/25/2013

400000

0.10

0.037

1.2915

04/14/2013

150000

0.10

0.034

1.3056

04/14/2013

600000

0.10

0.034

1.3056

05/15/2013

170000

0.10

0.037

1.2938

05/15/2013

680000

0.10

0.037

1.2938

06/24/2013

60000

0.10

0.025

1.3340

06/24/2013

240000

0.10

0.025

1.3340

08/05/2013

80000

0.10

0.018

1.3283

08/05/2013

320000

0.10

0.018

1.3283

03/01/2017

230000

0.025

03/01/2017

920000

0.025

10/18/2017

230000

0.025

10/18/2017

920000

0.025

06/01/2018

160000

0.025

06/01/2018

640000

0.025

11/10/2018

160000

0.025

11/10/2018

640000

0.025

06/15/2019

120000

0.025

06/15/2019

480000

0.025

12/20/2019

120000

0.025

12/20/2019

480000

0.025

06/15/2020

220000

0.025

06/15/2020

880000

0.025

12/15/2020

170000

0.025

12/15/2020

680000

0.025

08/15/2021

240000

0.025

08/15/2021

960000

0.025

04/30/2022

120000

0.025

04/30/2022

480000

0.025

08/15/2022

120000

0.025

08/15/2022

480000

0.025

37452000

33614000

71066000

190000 1200000 300000 reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above. 1840000 460000

0.025

The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018.

1280000 320000

0.025

The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum.

600000

0.025

The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

600000

0.025

The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

1100000

0.025

The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

850000

0.025

The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

1200000

0.025

The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

960000 240000

0.025

The first tranche of the promissory Notes of €480 and €120, respectively, were provided immediately. The second tranche of the promissory notes of €480 and €120, respectively, has been provided on August 15, 2022, with a 2.5% interest per annum.

156000

A first amortization installment of €14 is due on October 3, 2022. The next amortization of €14 will be due on March 31, 2023. The entire loan should be fully amortized by September 30, 2027.

Note 3. Commitments The facility lease agreement for Epalinges, Switzerland, is automatically renewed month by month with a notice period of three months. The related rent is paid monthly in the amount of €4 and is considered a short-term lease. As the term is less than twelve months, the lease is outside of the scope of ASC 842 and not accounted for on the balance sheet due to the Company’s policy elections. The facility lease agreement for Leiden, The Netherlands, runs until March 31, 2024, and can be terminated with a six month notice as of September 30, 2023. The related rent is paid monthly in the amount of €9. The Company does not have any other operating lease for its research and development facilities, corporate headquarter, offices and equipment.

4000

9000

EXCEL 26 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 27 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 28 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 29 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 219 169 1 false 71 0 false 5 false false R1.htm 000001 - Document - Cover Sheet http://mymx.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://mymx.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) Sheet http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) Statements 4 false false R5.htm 000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) Sheet http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) Statements 5 false false R6.htm 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 6 false false R7.htm 000007 - Disclosure - The Company and Summary of Significant Accounting Policies Sheet http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPolicies The Company and Summary of Significant Accounting Policies Notes 7 false false R8.htm 000008 - Disclosure - Debt Financing Sheet http://mymx.com/role/DebtFinancing Debt Financing Notes 8 false false R9.htm 000009 - Disclosure - Commitments Sheet http://mymx.com/role/Commitments Commitments Notes 9 false false R10.htm 000010 - Disclosure - The Company and Summary of Significant Accounting Policies (Policies) Sheet http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies The Company and Summary of Significant Accounting Policies (Policies) Policies http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPolicies 10 false false R11.htm 000011 - Disclosure - Debt Financing (Tables) Sheet http://mymx.com/role/DebtFinancingTables Debt Financing (Tables) Tables http://mymx.com/role/DebtFinancing 11 false false R12.htm 000012 - Disclosure - The Company and Summary of Significant Accounting Policies (Details Narrative) Sheet http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative The Company and Summary of Significant Accounting Policies (Details Narrative) Details http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies 12 false false R13.htm 000013 - Disclosure - Debt Financing (Details) Sheet http://mymx.com/role/DebtFinancingDetails Debt Financing (Details) Details http://mymx.com/role/DebtFinancingTables 13 false false R14.htm 000014 - Disclosure - Debt Financing (Details Narrative) Sheet http://mymx.com/role/DebtFinancingDetailsNarrative Debt Financing (Details Narrative) Details http://mymx.com/role/DebtFinancingTables 14 false false R15.htm 000015 - Disclosure - Commitments (Details Narrative) Sheet http://mymx.com/role/CommitmentsDetailsNarrative Commitments (Details Narrative) Details http://mymx.com/role/Commitments 15 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 13 fact(s) appearing in ix:hidden were eligible for transformation: mymx:BasicWeightedAndDilutedNumberOfShare, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding - mymx_10q.htm 1 mymx_10q.htm mymx-20220930.xsd mymx-20220930_cal.xml mymx-20220930_def.xml mymx-20220930_lab.xml mymx-20220930_pre.xml mymx_ex311.htm mymx_ex312.htm mymx_ex32.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 32 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mymx_10q.htm": { "axisCustom": 0, "axisStandard": 5, "contextCount": 219, "dts": { "calculationLink": { "local": [ "mymx-20220930_cal.xml" ] }, "definitionLink": { "local": [ "mymx-20220930_def.xml" ] }, "inline": { "local": [ "mymx_10q.htm" ] }, "labelLink": { "local": [ "mymx-20220930_lab.xml" ] }, "presentationLink": { "local": [ "mymx-20220930_pre.xml" ] }, "schema": { "local": [ "mymx-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 275, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 11, "http://mymx.com/20220930": 2, "http://xbrl.sec.gov/dei/2022": 5, "total": 18 }, "keyCustom": 38, "keyStandard": 131, "memberCustom": 67, "memberStandard": 4, "nsprefix": "mymx", "nsuri": "http://mymx.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "strong", "span", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://mymx.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "span", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - The Company and Summary of Significant Accounting Policies (Policies)", "role": "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "The Company and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - Debt Financing (Tables)", "role": "http://mymx.com/role/DebtFinancingTables", "shortName": "Debt Financing (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - The Company and Summary of Significant Accounting Policies (Details Narrative)", "role": "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "The Company and Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": "0", "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtDefaultShorttermDebtAmount", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - Debt Financing (Details)", "role": "http://mymx.com/role/DebtFinancingDetails", "shortName": "Debt Financing (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtDefaultShorttermDebtAmount", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ServicingAssetAtAmortizedValueRiskCharacteristicsDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - Debt Financing (Details Narrative)", "role": "http://mymx.com/role/DebtFinancingDetailsNarrative", "shortName": "Debt Financing (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ServicingAssetAtAmortizedValueRiskCharacteristicsDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30_mymx_SwitzerlandsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - Commitments (Details Narrative)", "role": "http://mymx.com/role/CommitmentsDetailsNarrative", "shortName": "Commitments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30_mymx_SwitzerlandsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://mymx.com/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherIncome", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)", "role": "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherIncome", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED)", "role": "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "-3", "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "role": "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - The Company and Summary of Significant Accounting Policies", "role": "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPolicies", "shortName": "The Company and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - Debt Financing", "role": "http://mymx.com/role/DebtFinancing", "shortName": "Debt Financing", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - Commitments", "role": "http://mymx.com/role/Commitments", "shortName": "Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 71, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address Address Line 3" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r378" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Security 12g Title" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "mymx_BasicAndDilutiveEarningsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and dilutive earnings per share" } } }, "localname": "BasicAndDilutiveEarningsPerShare", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "mymx_BasicWeightedAndDilutedNumberOfShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic weighted and diluted" } } }, "localname": "BasicWeightedAndDilutedNumberOfShare", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mymx_CarryingAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Carrying amount" } } }, "localname": "CarryingAmount", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_ConcentrationPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Concentration risk percentage" } } }, "localname": "ConcentrationPercentage", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "mymx_CoronavirusAidReliefAndEconomicSecurityActPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT" } } }, "localname": "CoronavirusAidReliefAndEconomicSecurityActPolicyTextBlock", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mymx_DebtInstrumentFaceValue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt instrument face value 1" } } }, "localname": "DebtInstrumentFaceValue1", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_DebtInstrumentFaceValue2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt instrument face value 2" } } }, "localname": "DebtInstrumentFaceValue2", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_DebtInstrumentFaceValue3": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt instrument face value 3" } } }, "localname": "DebtInstrumentFaceValue3", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_DescriptionOfConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of conversion price" } } }, "localname": "DescriptionOfConversionPrice", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "stringItemType" }, "mymx_DescriptionOfGrantAllocated": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grant allocated description" } } }, "localname": "DescriptionOfGrantAllocated", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "mymx_DescriptionOfOverallBudget": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Budget description" } } }, "localname": "DescriptionOfOverallBudget", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "mymx_ExceedCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Current liabilities exceeding current assets" } } }, "localname": "ExceedCurrentLiabilities", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_FirstYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First Year [Member]" } } }, "localname": "FirstYearMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_GrantRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grant Revenue [Member]" } } }, "localname": "GrantRevenueMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_Grants": { "auth_ref": [], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Grants" } } }, "localname": "Grants", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_ImpactOfNovelCoronavirusPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IMPACT OF THE NOVEL CORONAVIRUS" } } }, "localname": "ImpactOfNovelCoronavirusPolicyTextBlock", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mymx_IncomeTaxProvision": { "auth_ref": [], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Income tax provision" } } }, "localname": "IncomeTaxProvision", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_IncreaseDecreaseInOtherInterestPayableNet": { "auth_ref": [], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accrued interest on non-convertible notes payable" } } }, "localname": "IncreaseDecreaseInOtherInterestPayableNet", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_IncreaseDecreaseOther": { "auth_ref": [], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Other]", "verboseLabel": "Other" } } }, "localname": "IncreaseDecreaseOther", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_IssuanceDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the debt instrument was issued, in CCYY-MM-DD format.", "label": "Issuance date" } } }, "localname": "IssuanceDate", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "stringItemType" }, "mymx_NationalInstitutesOfHealthPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NIH" } } }, "localname": "NationalInstitutesOfHealthPolicyTextBlock", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mymx_NetLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Net loss]", "verboseLabel": "Net loss" } } }, "localname": "NetLoss", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_NetharlandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Netherlands [Member]" } } }, "localname": "NetharlandsMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_NoteEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 8 [Member]" } } }, "localname": "NoteEightMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 18 [Member]" } } }, "localname": "NoteEighteenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 11 [Member]" } } }, "localname": "NoteElevenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 15 [Member]" } } }, "localname": "NoteFiftteenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 58 [Member]" } } }, "localname": "NoteFiftyEightMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 55 [Member]" } } }, "localname": "NoteFiftyFiveMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 54 [Member]" } } }, "localname": "NoteFiftyFourMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 50 [Member]" } } }, "localname": "NoteFiftyMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 59 [Member]" } } }, "localname": "NoteFiftyNineMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 51 [Member]" } } }, "localname": "NoteFiftyOneMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 53 [Member]" } } }, "localname": "NoteFiftyThreeMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 52 [Member]" } } }, "localname": "NoteFiftyTwoMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFifySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 57 [Member]" } } }, "localname": "NoteFifySevenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFifySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 56 [Member]" } } }, "localname": "NoteFifySixMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 [Member]" } } }, "localname": "NoteFiveMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 48 [Member]" } } }, "localname": "NoteFortyEightMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 45 [Member]" } } }, "localname": "NoteFortyFiveMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 44 [Member]" } } }, "localname": "NoteFortyFourMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 40 [Member]" } } }, "localname": "NoteFortyMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 49 [Member]" } } }, "localname": "NoteFortyNineMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 41 [Member]" } } }, "localname": "NoteFortyOneMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 47 [Member]" } } }, "localname": "NoteFortySevenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 46 [Member]" } } }, "localname": "NoteFortySixMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 43 [Member]" } } }, "localname": "NoteFortyThreeMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 42 [Member]" } } }, "localname": "NoteFortyTwoMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 4 [Member]" } } }, "localname": "NoteFourMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 14 [Member]" } } }, "localname": "NoteFourteenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 [Member]" } } }, "localname": "NoteNineMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteNinteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 19 [Member]" } } }, "localname": "NoteNinteenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 1 [Member]" } } }, "localname": "NoteOneMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 [Member]" } } }, "localname": "NoteSevenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteSeventeenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 17 [Member]" } } }, "localname": "NoteSeventeenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 6 [Member]" } } }, "localname": "NoteSixMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteSixteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 16 [Member]" } } }, "localname": "NoteSixteenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteSixtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 60 [Member]" } } }, "localname": "NoteSixtyMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 10 [Member]" } } }, "localname": "NoteTenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 13 [Member]" } } }, "localname": "NoteThirteenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 3 [Member]" } } }, "localname": "NoteThreeMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 38 [Member]" } } }, "localname": "NoteThrityEightMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 35 [Member]" } } }, "localname": "NoteThrityFiveMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 34 [Member]" } } }, "localname": "NoteThrityFourMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 30 [Member]" } } }, "localname": "NoteThrityMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 39 [Member]" } } }, "localname": "NoteThrityNineMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 31 [Member]" } } }, "localname": "NoteThrityOneMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThritySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 37 [Member]" } } }, "localname": "NoteThritySevenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThritySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 36 [Member]" } } }, "localname": "NoteThritySixMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 33 [Member]" } } }, "localname": "NoteThrityThreeMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 32 [Member]" } } }, "localname": "NoteThrityTwoMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 28 [Member]" } } }, "localname": "NoteTwentyEightMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 25 [Member]" } } }, "localname": "NoteTwentyFiveMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 24 [Member]" } } }, "localname": "NoteTwentyFourMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 20 [Member]" } } }, "localname": "NoteTwentyMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 29 [Member]" } } }, "localname": "NoteTwentyNineMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 21 [Member]" } } }, "localname": "NoteTwentyOneMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 27 [Member]" } } }, "localname": "NoteTwentySevenMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 26 [Member]" } } }, "localname": "NoteTwentySixMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 23 [Member]" } } }, "localname": "NoteTwentyThreeMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 22 [Member]" } } }, "localname": "NoteTwentyTwoMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwevleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 12 [Member]" } } }, "localname": "NoteTwevleMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 2 [Member]" } } }, "localname": "NoteTwoMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_OptionToLicenseAgreementAnergisSaPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Option to License Agreement ANERGIS SA" } } }, "localname": "OptionToLicenseAgreementAnergisSaPolicyTextBlock", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mymx_PromissoryNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes" } } }, "localname": "PromissoryNotes", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotes1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes 1" } } }, "localname": "PromissoryNotes1", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotes2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes 2" } } }, "localname": "PromissoryNotes2", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotesEardleyHoldingAg": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes Eardley Holding AG" } } }, "localname": "PromissoryNotesEardleyHoldingAg", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotesRoundEnterprisesLtd": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes Round Enterprises" } } }, "localname": "PromissoryNotesRoundEnterprisesLtd", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotesTranches1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes Tranches 1" } } }, "localname": "PromissoryNotesTranches1", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotesTranches2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes Tranches 2" } } }, "localname": "PromissoryNotesTranches2", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_ReceivedFromFederalCreditLine": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Received from federal credit line" } } }, "localname": "ReceivedFromFederalCreditLine", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_RelatedPartyTransactionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsPolicyTextBlock", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mymx_SecondYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Second Year [Member]" } } }, "localname": "SecondYearMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Option [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_SubAwardGrantRevenueEuro": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Sub award grant revenue euro" } } }, "localname": "SubAwardGrantRevenueEuro", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_SubAwardGrantRevenueUSDollar": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Sub award grant revenue USD" } } }, "localname": "SubAwardGrantRevenueUSDollar", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_SubAwardProjectCostEuro": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Sub award project cost euro" } } }, "localname": "SubAwardProjectCostEuro", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_SubAwardProjectCostUSDollar": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Sub award project cost USD" } } }, "localname": "SubAwardProjectCostUSDollar", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_SwitzerlandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Switzerlands [Member]" } } }, "localname": "SwitzerlandsMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_ThirdYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Year [Member]" } } }, "localname": "ThirdYearMember", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_TranslationAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Translation adjustment" } } }, "localname": "TranslationAdjustment", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_WeightedAverageNumberOfSharesContingentlyConvertibleLoans": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Potentially shares issuable convertible loans" } } }, "localname": "WeightedAverageNumberOfSharesContingentlyConvertibleLoans", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mymx_WeightedAverageSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted-average shares outstanding, basic and diluted" } } }, "localname": "WeightedAverageSharesOutstandingBasicAndDiluted", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "sharesItemType" }, "mymx_WithholdingTaxesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WITHHOLDING TAXES" } } }, "localname": "WithholdingTaxesPolicyTextBlock", "nsuri": "http://mymx.com/20220930", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r37", "r39", "r84", "r85", "r187", "r219" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r38", "r39", "r84", "r85", "r187", "r219" ], "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "The Company and Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r29", "r305" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r131", "r132" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r10", "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Property and equipment, accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r22", "r42", "r44", "r45", "r356", "r369", "r370" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r41", "r45", "r52", "r53", "r54", "r88", "r89", "r90", "r270", "r301", "r365", "r366" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r20", "r305" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r88", "r89", "r90", "r250", "r251", "r252", "r277" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "APIC" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r13", "r82", "r117", "r120", "r126", "r144", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r265", "r271", "r282", "r303", "r305", "r341", "r355" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "verboseLabel": "Total" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r27", "r82", "r144", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r265", "r271", "r282", "r303", "r305" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "BASIS OF PRESENTATION AND GOING CONCERN" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "CASH" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r66", "r73", "r76" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents]", "periodEndLabel": "Cash, end of period", "periodStartLabel": "Cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r66", "r284" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r9" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r35", "r345", "r360" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies (Note 3)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r168", "r169", "r170", "r171", "r373" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/Commitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r88", "r89", "r277" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r221" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r19", "r305" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, U.S. $0.01 par value; 1,200,000,000 shares authorized; issued and outstanding 303,757,622 at September 30, 2022 and at December 31, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r47", "r49", "r50", "r59", "r348", "r362" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r107", "r353" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r77", "r267" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "PRINCIPLES OF CONSOLIDATION" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r31" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable and related accrued interest to related parties" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r60" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Expenses total" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDefaultShorttermDebtAmount": { "auth_ref": [ "r80" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of outstanding short-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured.", "label": "Total short term principal amounts" } } }, "localname": "DebtDefaultShorttermDebtAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Financing" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r80", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r200", "r207", "r208", "r210", "r216" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt Financing" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancing" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "auth_ref": [ "r16" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the total principal payments made during the annual reporting period.", "label": "Principal amount" } } }, "localname": "DebtInstrumentAnnualPrincipalPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r14", "r15", "r16", "r81", "r86", "r183", "r184", "r185", "r186", "r187", "r188", "r190", "r196", "r197", "r198", "r199", "r201", "r202", "r203", "r204", "r205", "r206", "r212", "r213", "r214", "r215", "r297", "r342", "r343", "r354" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r185", "r211" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r14", "r16", "r222", "r342", "r343", "r352", "r354" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt instruments description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r198", "r212", "r213", "r281" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Total loans and notes", "verboseLabel": "Total loans and notes" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r81" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r33", "r184" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r34", "r81", "r86", "r183", "r184", "r185", "r186", "r187", "r188", "r190", "r196", "r197", "r198", "r199", "r201", "r202", "r203", "r204", "r205", "r206", "r212", "r213", "r214", "r215", "r297" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r12" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Rent deposit" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r71", "r164" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r284" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect on foreign exchange rate on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r52", "r53", "r54", "r88", "r89", "r90", "r92", "r97", "r99", "r104", "r145", "r221", "r223", "r250", "r251", "r252", "r262", "r263", "r277", "r285", "r286", "r287", "r288", "r289", "r291", "r301", "r365", "r366", "r367" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r279", "r280" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "FAIR VALUES OF FINANCIAL INSTRUMENTS" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r139", "r140", "r141", "r142", "r143", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r209", "r220", "r276", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r334", "r335", "r336", "r381", "r382", "r383", "r384", "r385", "r386", "r387" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r292", "r293" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Fixed rate conversion" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "FOREIGN CURRENCY TRANSLATION" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r11", "r157", "r158", "r159", "r161", "r305", "r340" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r160", "r161", "r162" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "GOODWILL" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r163", "r167" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "IMPAIRMENT OF LONG LIVED ASSETS" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r57", "r117", "r119", "r122", "r125", "r127", "r339", "r346", "r350", "r363" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Loss before income tax provision" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r51", "r256", "r257", "r258", "r259", "r260", "r261" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "TAXES ON INCOME" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r67", "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "[Income Taxes Paid]", "negatedLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r70" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "[Increase (Decrease) in Accounts Payable]", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r70" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Accrued interest on convertible notes payable" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherDeferredLiability": { "auth_ref": [ "r70" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred obligations classified as other.", "label": "Deferred grant" } } }, "localname": "IncreaseDecreaseInOtherDeferredLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r70" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "[Increase (Decrease) in Receivables]", "negatedLabel": "Receivables" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r55", "r116", "r295", "r296", "r349" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "[Investment Interest Rate]", "verboseLabel": "Interest rate" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "LEASES" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r30", "r82", "r121", "r144", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r266", "r271", "r272", "r282", "r303", "r304" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r25", "r82", "r144", "r282", "r305", "r344", "r358" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Total liabilities and shareholders' deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r5", "r32", "r82", "r144", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r266", "r271", "r272", "r282", "r303", "r304", "r305" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r6", "r7", "r8", "r16", "r17", "r82", "r144", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r266", "r271", "r272", "r282", "r303", "r304" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Total long-term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r16" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Debt-Principal Payable to the Federal Financing Bank" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r66" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r66" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 15.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r66", "r69", "r72" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 16.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r46", "r48", "r54", "r58", "r72", "r82", "r91", "r93", "r94", "r95", "r96", "r98", "r99", "r101", "r117", "r119", "r122", "r125", "r127", "r144", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r278", "r282", "r347", "r361" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 15.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited", "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "NEW ACCOUNTING PRONOUNCEMENT" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r28", "r83", "r302" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Non-convertible notes payable and related accrued interest to related parties" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r117", "r119", "r122", "r125", "r127" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 9.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r299" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r299" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability1" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r298" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right-of-Use Asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r2", "r87", "r113", "r275" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "verboseLabel": "The Company and Summary of Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r40", "r43", "r283", "r290" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 14.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "[Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax]", "negatedLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "auth_ref": [ "r61" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense classified as other.", "label": "General and administrative" } } }, "localname": "OtherGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r364" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r62" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other (income) expense" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Rent paid per month" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r63" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "[Payments to Acquire Property, Plant, and Equipment]", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18", "r218" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18", "r218" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r18", "r305" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none-issued or Outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r26", "r155", "r156" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromFederalHomeLoanBankBorrowings": { "auth_ref": [ "r64" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from Federal Home Loan Bank (FHLBank) borrowing, classified as financing activity.", "label": "Proceeds from borrowing on-line of credit with federal bank" } } }, "localname": "ProceedsFromFederalHomeLoanBankBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r64" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from issuance of non-convertible notes" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r371", "r372" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r46", "r48", "r54", "r65", "r82", "r91", "r98", "r99", "r117", "r119", "r122", "r125", "r127", "r144", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r264", "r268", "r269", "r273", "r274", "r278", "r282", "r350" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]", "negatedLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r166", "r305", "r351", "r359" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net of accumulated depreciation of ?483 at September 30, 2022 and ?474 at December 31, 2021" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r166", "r374", "r375" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r133", "r135", "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "RECEIVABLES" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned": { "auth_ref": [ "r254", "r255" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 4.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.", "label": "Research and development1" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r253", "r337", "r376" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "RESEARCH AND DEVELOPMENT" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r21", "r223", "r305", "r357", "r368", "r370" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r88", "r89", "r90", "r92", "r97", "r99", "r145", "r250", "r251", "r252", "r262", "r263", "r277", "r365", "r367" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "REVENUE RECOGNITION" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r56", "r82", "r114", "r115", "r118", "r123", "r124", "r128", "r129", "r130", "r144", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r282", "r350" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenue total" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Convertible notes, loans and contingent liabilities" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ServicingAssetAtAmortizedValueRiskCharacteristicsDescription": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Description of the risk characteristics of the underlying financial assets for servicing assets that are subsequently measured using the amortization method.", "label": "Amortization installment description" } } }, "localname": "ServicingAssetAtAmortizedValueRiskCharacteristicsDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r36", "r52", "r53", "r54", "r88", "r89", "r90", "r92", "r97", "r99", "r104", "r145", "r221", "r223", "r250", "r251", "r252", "r262", "r263", "r277", "r285", "r286", "r287", "r288", "r289", "r291", "r301", "r365", "r366", "r367" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative", "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited", "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r88", "r89", "r90", "r104", "r338" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative", "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited", "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r23", "r24", "r82", "r134", "r144", "r282", "r305" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Total shareholders' deficit", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets", "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityPolicyTextBlock": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.", "label": "PREFERRED STOCK" } } }, "localname": "StockholdersEquityPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosure of Cash Flow Information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r139", "r140", "r141", "r142", "r143", "r209", "r220", "r276", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r334", "r335", "r336", "r381", "r382", "r383", "r384", "r385", "r386", "r387" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r105", "r106", "r108", "r109", "r110", "r111", "r112" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "ESTIMATES" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.", "label": "Potentially shares issuable" } } }, "localname": "WeightedAverageNumberOfSharesContingentlyIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r162": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r171": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r216": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r275": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r294": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(d)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r377": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r378": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r379": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r380": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r381": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r382": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r383": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r384": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r385": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r386": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r387": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r388": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r87": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" } }, "version": "2.1" } ZIP 33 0001654954-22-015183-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-22-015183-xbrl.zip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end